https://rjrindex.com/articles/trends-and-disparities-in-lung-cancer-and-respiratory-failure-mortality-in-the-us-a-24-year-retrosp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-adjuvant-systemic-cancer-therapies-on-health-related-quality-of-life-a-systematic-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-elevated-expression-of-ililrb4i-and-itsc22d3i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-obesity-biomarkers-and-breast-cancer-risk-in-nigeria 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influenza-and-covid-19-vaccination-uptake-among-cancer-survivors-in-the-us 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-cost-and-insurance-on-receipt-of-guideline-concordant-mammography 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathological-features-and-prognostic-implications-of-her2-low-in-early-stage-male-breast-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-open-label-single-arm-phase-iii-study-to-assess-the-efficacy-and-safety-of-wsd0922 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-first-line-1l-domvanalimab-dom-zimberelimab-zim-and-chemotherapy-chemo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-of-cardiac-monitoring-and-outcomes-in-patients-with-her2-positive-breast-cancer-treated-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/osimertinib-plus-repotrectinib-phase-i-trial-in-tki-resistant-non-small-cell-lung-cancer-nsclc-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-adverse-effect-profile-of-pd-1-and-ctla-4-inhibitors-and-its-variation-with-race-and-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-temozolomide-on-dendritic-cell-vaccine-for-glioblastoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-decisional-needs-of-patients-considering-first-line-treatment-of-advanced-egfr-lung-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-neoadjuvant-therapy-in-advanced-melanoma-a-systematic-review-and-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-features-associated-with-an-exceptional-response-to-immunotherapy-in-patients-with-metastat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oncologists-preferences-for-first-line-1l-treatment-of-alk-positive-metastatic-nsclc-in-the-us-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/aiding-data-retrieval-in-clinical-trials-with-large-language-models-the-apollo-11-consortium-in-adv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/autoimmune-conditions-and-breast-implant-illness-in-breast-cancer-patients-with-implant-based-brea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-hpv-dna-dynamics-and-neoadjuvant-chemotherapy-with-or-without-nivolumab-in-viral-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/recurrence-patterns-in-the-prospective-randomized-controlled-multicenter-phase-iii-esopec-trial-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/managing-the-invisible-treatment-approaches-after-pathological-complete-response-pcr-to-neoadjuva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dynamic-combined-monitoring-of-sii-and-pni-in-evaluating-the-prognostic-impact-on-advanced-driver-ge 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-iii-trial-evaluating-addition-of-adjuvant-chemotherapy-to-ovarian-function-suppression-end-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/frontline-brentuximab-vedotin-bv-and-chp-in-patients-pts-with-peripheral-t-cell-lymphoma-ptcl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-alectinib-in-pediatric-and-adult-patients-with-alk-altered-advanced-solid-tum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/actionable-gene-alterations-in-resected-non-small-cell-lung-cancer-aga-r-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pregnancy-associated-breast-cancer-tumor-infiltrating-lymphocytes-tilting-the-balance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/feasibility-of-circulating-tumor-dna-based-minimal-residual-disease-ctdna-mrd-guided-adjuvant-chem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/retracted-disability-adjusted-life-years-from-human-papillomavirus-related-oral-cavity-and-pharynx 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-first-in-human-study-of-regorafenib-plus-temozolomide-with-or-without-radiotherapy-in-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunotherapy-in-patients-with-early-stage-microsatellite-instable-msi-hmismatch-repair-deficient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/irradiated-tumor-volume-as-a-predictor-of-local-recurrence-and-radionecrosis-in-lung-cancer-with-bra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tissue-free-circulating-tumor-dna-assay-and-patient-outcome-in-a-phase-iii-trial-of-folfox-based-adj-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-by-baseline-tumor-burden-using-the-6-and-12-score-in-emerald-1-a-phase-3-study-of-durvalum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-trends-in-second-primary-malignancy-in-patients-with-renal-cell-carcinoma-a-retrospective-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/successful-induction-of-tumor-directed-immune-responses-in-high-grade-serious-ovarian-carcinoma-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-ocular-conditions-and-risk-of-ocular-events-in-patients-pts-with-relapsedrefractory-mult 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-therapeutic-vaccine-for-fibrolamellar-hepatocellular-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-the-efficacy-of-gemox-lenvatinib-after-gemox-sorafenib-failure-in-unresectable-fibrolame 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-effectiveness-of-mental-health-interventions-on-anxiety-depression-and-quality-of-life 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-the-combination-of-systemic-and-locoregional-therapy-on-tumor-recurrence-and-survival-afte 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-of-radiation-necrosis-with-concurrent-antibody-drug-conjugates-and-radiotherapy-in-her2-positiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-gene-signature-for-the-efficacy-of-pazopanib-in-solitary-fibrous-tumor-a-spanish-group-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-the-association-between-peak-post-infusion-absolute-lymphocyte-count-alc-and-delayed 2026-08-24 monthly 0.7 https://rjrindex.com/articles/primary-endpoint-results-of-the-phase-3b-asc4start-trial-of-asciminib-asc-vs-nilotinib-nil-in-ne 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mechanism-of-deptor-in-promoting-gemcitabine-resistance-in-pancreatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-preliminary-results-of-a-randomized-phase-ii-trial-evaluating-induction-toripalimab-plus-chemoth 2026-08-24 monthly 0.7 https://rjrindex.com/articles/claudin182-cldn182-expression-and-efficacy-in-pancreatic-ductal-adenocarcinoma-pdac-results-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-trial-of-sys6010-combined-with-syh2051-in-patients-with-advanced-gastrointestinal-tum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pd-1-directed-intratumoral-immunotherapy-for-cutaneous-carcinomas-interim-results-from-an-ongoing-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multidisciplinary-approach-for-treatment-choice-in-cancer-patients-with-cardiovascular-diseases-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/logic-gated-allogeneic-tmod-chimeric-antigen-receptor-t-cell-car-t-therapy-targeting-epidermal-gr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/engineered-aav-vectors-with-dual-tumor-specific-promoters-for-safer-and-more-effective-cancer-therap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-first-in-human-clinical-study-of-9mw2921-a-novel-trop-2-antibody-drug-conjugate-adc-in-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-impact-of-trastuzumab-based-therapy-in-her2-positive-advanced-gastric-cancer-evidence-fr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unique-mutational-landscape-and-therapeutic-implications-in-non-small-cell-lung-cancer-with-comorbid 2026-08-24 monthly 0.7 https://rjrindex.com/articles/revolutionizing-bladder-cancer-follow-up-personalized-urinary-ctdna-analysis-for-detecting-minimal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rasbraf-testing-of-circulating-cell-free-dna-cfdna-in-rasbraf-wild-type-rasbraf-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-efficacy-and-safety-of-eutideron-etoposide-and-bevacizumab-in-patients-with-brain-metastases-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iii-study-of-the-ep4-antagonist-vorbipiprant-combined-with-anti-pd-1-immunotherapy-safety-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/advanced-lung-cancer-inflammation-index-ali-as-a-prognostic-marker-for-locally-advanced-and-metast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-results-of-afatinib-plus-chemotherapy-with-genomic-profiling-in-osimertinib-refractory-egfr-mu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-daratumumab-for-treating-multiple-myeloma-in-patients-with-high-risk-cytogenetic-facto 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trend-analysis-of-risk-factors-for-early-onset-primary-colorectal-cancer-a-population-based-time-tr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-short-course-radiotherapy-scrt-followed-by-consolidation-chemotherapy-with-folfo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/teluride-006-an-adaptive-phase-23-study-of-eik1001-a-toll-like-receptor-78-tlr78-agonist-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/triple-negative-breast-cancer-insights-from-the-mexican-population 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differences-in-age-of-diagnosis-and-survival-period-for-individuals-of-asian-indianpakistani-origin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/using-longitudinal-spatial-omics-to-demonstrate-in-situ-epstein-barr-virus-reduction-in-responders-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-and-patterns-of-recurrence-and-the-impact-of-adjuvant-radiation-in-early-stage-pt1-2-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ctdna-guided-treatment-stratification-for-nasopharyngeal-carcinoma-patients-a-retrospective-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/deep-learning-algorithm-for-accurate-diagnosis-of-oral-cancer-and-precancers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/navigating-neutropenia-in-oncology-insights-into-clinical-characteristics-and-outcomes-from-a-brazi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-assessment-of-end-of-life-care-among-patients-with-gastrointestinal-cancers-who-died-inpatient-at 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reassessing-colorectal-cancer-recurrence-in-solid-organ-transplant-recipients-implications-for-revi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-patients-treated-with-dabrafenib-and-trametinib-who-developed-pyrexia-syndrome-and-sever 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-efficacy-of-benzydamine-and-alternative-mouthwashes-in-the-management-of-oral-mucositis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hematologic-and-systemic-complications-of-bispecific-antibodies-insights-from-a-national-inpatient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-body-mass-index-change-and-insulin-resistance-with-survival-during-induction-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/palliative-care-and-hospice-utilization-in-patients-with-refractory-or-relapsed-diffuse-large-b-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/understanding-patient-anxiety-at-pre-and-post-consultation-with-gynecologic-oncology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pd-1-blockade-in-combination-with-bevacizumab-and-nab-paclitaxel-for-second-line-treatment-in-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/itp53i-genomic-alterations-including-targetable-itp53i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/vabametkib-in-met-exon-14-skipping-non-small-cell-lung-cancer-efficacy-and-safety-from-the-open-lab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-initial-vs-delayed-docetaxel-therapy-in-veterans-with-metastatic-hormone-sensitive-prost 2026-08-24 monthly 0.7 https://rjrindex.com/articles/expand-1-a-phase-iii-study-with-anv600-a-novel-pd-1-targeted-il-2r-vgh-agonist-in-monotherapy-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cardiac-involvement-in-erdheim-chester-disease-a-systematic-review-of-presentation-management-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-novel-nomogram-for-predicting-treatment-and-prognosis-in-primary-gastric-squamous-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-continuous-temperature-monitoring-at-a-community-cancer-center-towards-a-new-standard-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-generative-ai-models-for-development-of-patient-education-quizzes-on-hormone-related-symp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-ak117-combined-with-cetuximab-or-ak104-in-the-treatment-of-recurrent-or-metastat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-second-primary-malignancies-spms-in-head-and-neck-cancer-survivors-stratified-by-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-stage-at-diagnosis-as-an-indicator-of-cancer-screening-efficacy-in-diverse-populations 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-expansions-of-or502-an-antibody-targeting-leukocyte-immunoglobulin-like-receptor-b2-lilrb2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographic-and-regional-trends-in-female-genital-neoplasm-mortality-in-the-united-states-from-1999 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-the-covid-19-pandemic-on-inpatient-outcomes-for-cancer-patients-in-the-united-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/management-and-outcomes-of-rash-peripheral-neuropathy-pn-and-hyperglycemia-hg-during-first-lin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/activating-aml-patients-through-empowering-cancer-communication-strategies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-expanding-medicaid-contracts-at-dana-farber-cancer-institute 2026-08-24 monthly 0.7 https://rjrindex.com/articles/concomitant-treatment-with-2nd-generation-hormone-therapy-and-177lut-psma-versus-177lut-psma-alone 2026-08-24 monthly 0.7 https://rjrindex.com/articles/plasma-proteome-molecular-sequencing-based-prognostic-nomogram-in-metastatic-castrate-resistant-pros 2026-08-24 monthly 0.7 https://rjrindex.com/articles/serum-estradiol-se2-levels-in-premenopausal-prem-women-receiving-neoadjuvant-ovarian-function-su 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-following-enzalutamide-resistance-in-metastatic-castration-sensitive-versus-metasta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/allogeneic-hematopoietic-cell-transplantation-for-acute-leukemia-patients-not-in-complete-remission 2026-08-24 monthly 0.7 https://rjrindex.com/articles/second-line-therapy-following-osimertinib-in-metastatic-egfr-mutated-non-small-cell-lung-cancer-at-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-prostate-cancer-patients-hospitalized-with-viral-respiratory-illnesses-a-national-popul 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-lifestyle-factors-and-pathological-characteristics-in-patients-with-early-breast-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beyond-the-5-year-mark-adherence-to-and-continuation-of-extended-adjuvant-endocrine-therapy-in-non 2026-08-24 monthly 0.7 https://rjrindex.com/articles/strategic-planning-to-transform-pancreatic-cancer-care-a-comprehensive-interdisciplinary-roadmap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intervention-adherence-engagement-and-tool-utilization-in-the-breast-cancer-weight-loss-bwel-tria 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-results-of-the-french-multicenter-randomized-share-trial-comparing-whole-breast-irradiation-v 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-azacitidine-in-the-treatment-of-elderly-patients-with-higher-risk-myelodyspla 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-clinical-outcome-of-sacituzumab-govitecan-sg-in-her2-negative-metastatic-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-survival-benefit-with-immunotherapy-in-combination-with-adjuvant-chemoradiation-in-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-neoadjuvant-immunotherapy-for-mismatch-repair-deficient-colorectal-cancer-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exposure-to-magnetic-resonance-imaging-mri-procedures-in-relation-to-increased-risk-of-early-onset 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-open-label-phase-12-study-of-dcc-3009-monotherapy-in-patients-with-advanced-gastrointestinal-str 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-outcomes-in-gist-trial-13-162-phase-ii-study-of-imatinib-in-combination-with-binimetinib 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-experience-of-melphalanhepatic-delivery-system-with-circulating-tumor-dna-ctdna-monito 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-ctdna-and-hematologic-ratios-as-markers-of-disease-progression-in-early-versus-late-st 2026-08-24 monthly 0.7 https://rjrindex.com/articles/plasma-extracellular-vesicles-as-biomarkers-of-primary-versus-acquired-resistance-to-immune-checkpoi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/informing-the-gravid-void-a-population-based-study-of-live-birth-rates-after-oncologic-immunotherap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-adverse-outcomes-septicemias-healthcare-complications-coagulopathies-and-cardiac-arrhyt 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hepatocellular-carcinoma-patients-with-portal-vein-thrombosis-treated-with-robotic-radiosurgery-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-study-of-sustained-and-local-delivery-of-intraperitoneal-il-2-using-encapsulated-cells-in-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dissecting-publication-timelines-insights-from-high-impact-oncology-journals 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-dynamic-blood-flow-device-with-conjugated-affinity-ligands-on-glass-substrate-to-capture-circ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-efficacy-and-pharmacokinetics-pk-of-ts-1-combined-with-cisplatin-in-advanced-cancer-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploration-of-the-evolving-role-of-sup18sup-f-fdg-petct-in-evaluating 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-effectiveness-of-fuzuloparib-in-patients-with-ovarian-cancer-a-nationwide-multicenter 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-and-survival-outcomes-in-ovarian-carcinosarcoma-compared-to-serous-carcinom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-and-survival-outcomes-in-uterine-carcinosarcoma-a-population-based-analysi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-sleep-quality-and-quality-of-life-among-patients-newly-diagnosed-with-head-and-neck-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-uptake-of-targeted-agents-by-raceethnicity-in-patients-receiving-first-line-treatment-fo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-receipt-of-chemotherapy-at-the-end-of-life-among-patients-with-nsclc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-trends-of-early-onset-cancers-15-49-years-1990-2021-and-projection-to-2040 2026-08-24 monthly 0.7 https://rjrindex.com/articles/high-dose-13-bis-2-chloroethyl-1-nitrosourea-bcnu-chemoembolization-for-treatment-naive-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/vulnerability-cartography-a-narrative-review-of-the-historical-epidemiological-and-biocultural-pe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identifying-breast-cancer-diagnosis-stages-in-high-risk-patients-using-a-population-genetic-screenin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-histology-agnostic-biomarkers-in-pure-squamous-cell-carcinomas-of-the-genitourinary-tr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intensive-surveillance-and-aggressive-multi-modal-treatment-for-liver-metastases-from-uveal-melanoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lung-cancer-screening-for-high-risk-patients-a-quality-improvement-initiative-to-improve-guideline 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trick-mcc-final-results-from-the-proof-of-concept-investigator-initiated-study-of-combination-thera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dna-methylation-biomarkers-of-cardiotoxicity-risk-in-breast-cancer-patients-treated-with-anthracycli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-novel-staging-system-for-cancer-cachexia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-novel-agent-para-toluenesulfonamide-for-the-management-of-malignant-pleural-effusions 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-retrospective-analysis-of-taxane-based-chemotherapy-in-small-bowel-adenocarcinoma-sba 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-cannabis-use-on-patient-outcomes-post-immune-checkpoint-inhibitor-ici-therapy-in-a-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-trastuzumab-safety-in-tailored-dose-dense-anthracycline-containing-adjuvant-chemotherapy-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-i-study-of-tr64-a-vegfrcsf1rc-kit-small-molecule-inhibitor-for-the-treatment-of-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-survival-in-patients-undergoing-surgery-for-pancreatic-ductal-adenocarcinoma-using-liq 2026-08-24 monthly 0.7 https://rjrindex.com/articles/big-data-analysis-of-outcomes-in-non-small-cell-lung-cancer-at-a-regional-cancer-institute-with-a-co 2026-08-24 monthly 0.7 https://rjrindex.com/articles/leveraging-the-power-of-diagnostic-metrics-to-competency-based-medical-education-cbme-implementati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-cell-free-dna-ccfdna-fragmentomics-for-early-detection-of-colorectal-carcinoma-a-syst 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-role-of-baseline-levels-and-early-changes-of-systemic-inflammatory-indexes-for-avelumab-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-educational-experiences-through-standardization-of-inpatient-hematology-curriculums 2026-08-24 monthly 0.7 https://rjrindex.com/articles/using-live-true-single-circulating-tumor-cell-comprehensive-genomics-to-show-clonal-evolution-and-tu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-toripalimab-in-high-risk-renal-cell-carcinoma-after-tumor-resection-tuoad-rcc-a-prospect 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cosiporfin-sodium-dvdms-mediated-photodynamic-therapy-pdt-versus-treatment-of-physicians-choice 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-based-predictive-tool-for-detection-of-ctdna-in-pancreatic-adenocarcinoma-using-nationwide-compre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-competence-and-confidence-in-thoracic-oncology-a-pilot-study-on-the-impact-of-self-assess 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-skin-toxicity-as-a-predictor-of-response-in-urothelial-carcinoma-patients-treated-with-enf 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intelligent-sers-navigation-system-to-guide-lung-cancer-surgery-through-intraoperative-metabolic-aci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/examining-the-impact-of-socioeconomic-factors-on-survival-and-treatment-outcomes-in-primary-intraocu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-derived-b-cell-epitopes-classifiers-for-early-detection-of-renal-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-unseen-burden-of-ctcl-caregiving 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-obesity-on-car-t-cell-therapy-outcomes-in-diffuse-large-b-cell-lymphoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multiomics-profiling-for-prediction-of-immunotherapy-response-in-advanced-pleural-mesothelioma-sub 2026-08-24 monthly 0.7 https://rjrindex.com/articles/vasculogenic-mimicry-as-a-potential-indicator-of-drug-resistance-and-prognosis-in-renal-cell-carcino 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-factors-for-surgically-resected-pulmonary-large-cell-neuroendocrine-carcinoma-a-single-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ngs-testing-for-patient-selection-in-left-sided-rasbraf-wild-type-metastatic-colorectal-cancer-rece 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radiomic-signatures-as-predictors-of-pathological-response-to-neoadjuvant-chemoimmunotherapy-in-surg 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-enrichment-of-cd7cxcr3-car-t-cells-in-infusion-products-with-remission-in-relapsed 2026-08-24 monthly 0.7 https://rjrindex.com/articles/distinct-outcomes-with-the-detection-of-endemic-burkitt-lymphoma-t-cell-receptor-tcr-complementar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-assessment-from-liquid-biopsy-of-mutations-in-cd20-a-pilot-study-using-a-pete-enrichme 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiology-of-imeti-gene-mrna-expression-in-metastatic-colorectal-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-extent-of-surgical-resection-on-survival-outcomes-in-patients-with-idh-mutant-anaplastic-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-the-prevalence-of-germline-mutations-in-young-onset-biliary-tract-cancer-btc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/anemia-as-a-predictive-factor-for-brain-metastases-a-propensity-score-matched-retrospective-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-surufatinib-sur-plus-paclitaxel-pac-as-second-line-2l-treatment-for-adv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-results-of-a-phase-ii-study-of-rc48-in-combination-with-tislelizumab-as-pre-transurethral-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-nivolumab-plus-ipilimumab-versus-immune-checkpoint-inhibitor-and-tyrosine-kin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-expansion-study-of-ff-10832-liposomal-gemcitabine-antitumor-activity-in-patients-with-adva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/recurrence-free-survival-as-a-surrogate-endpoint-for-overall-survival-in-resectable-esophageal-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/using-preprocedural-clinical-factors-and-ct-radiomics-to-predict-hepatocellular-carcinoma-response-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/repurposing-itraconazole-for-secondary-prevention-of-metaplasia-and-primary-prevention-of-cancer-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-racial-disparities-in-biliary-tract-cancer-with-sepsis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-perioperative-and-neoadjuvant-therapies-in-gastric-and-gastroesophageal-gej-adenocarci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unveiling-the-power-of-parp-inhibitors-a-meta-analysis-on-newly-diagnosed-advanced-ovarian-cancer-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ib-open-label-trial-of-mov18-ige-in-patients-with-advanced-ovarian-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/understanding-disparities-in-survival-outcomes-for-early-onset-gastric-cancer-a-comprehensive-multi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/short-course-radiotherapy-followed-by-capox-combined-with-tislelizumab-and-bevacizumab-or-cetuximab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-profiling-of-patients-with-metastatic-luminal-her2-low-and-her2-0-breast-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-landscapes-of-hrher2-metastatic-breast-cancer-insights-from-ctdna-profiling-in-the-us-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-prognostic-value-of-acneiform-rash-grade-in-metastatic-colorectal-cancer-patients-treated-with-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/regorafenib-and-nivolumab-in-refractory-microsatellite-stable-metastatic-colorectal-cancer-and-impa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/application-of-quantile-regression-forest-for-early-detection-of-sarcopenia-in-oncogeriatric-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/older-onset-hereditary-breast-and-ovarian-cancer-hboc-syndrome-patients-and-clinical-value-of-germ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-immune-checkpoint-inhibitors-in-smokers-vs-non-smokers-a-large-real-world-retrospective 2026-08-24 monthly 0.7 https://rjrindex.com/articles/single-cell-rna-sequencing-atlas-of-intestinal-injury-induced-by-different-clinical-treatments-in-co 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-telehealth-means-i-get-distance-from-the-hospital-so-i-dont-feel-so-much-like-a-patient-a-qu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/general-practitioner-led-vs-surgeon-led-colon-cancer-survivorship-care-a-randomized-clinical-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/communication-of-uncertainties-about-recent-cancer-drugs-in-large-language-models 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-analysis-of-folate-receptor-alpha-fra-folr1-expression-in-pan-tumor-samples-from-over 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multimodal-deep-learning-model-for-early-prediction-of-pancreatic-cancer-progression 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-imwg-and-pangea-risk-models-predicting-mgus-to-multiple-myeloma-progression-in-a-safet 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-phase-1-dose-escalation-trial-of-omtx705-a-novel-anti-fibroblast-activation-protein 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-safety-of-belzutifan-in-von-hippel-lindausyndrome-a-single-center-experience 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-with-targeted-therapy-for-nras-mutated-melanoma-a-systematic-review-and-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/extended-endocrine-therapy-after-5-years-of-adjuvant-lhrh-agonist-in-premenopausal-patients-with-nod 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-study-results-of-jnj-78278343-pasritamig-in-metastatic-castration-resistant-prostate-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-an-anti-telomerase-cd4-t-helper-vaccine-ucpvax-with-or-without-temozolomide-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigation-of-tumor-associated-macrophages-tams-and-therapeutic-resistance-to-immune-checkpoint 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-newborn-screening-for-cancer-risk-a-retrospective-cohort-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/precemtabart-tocentecan-m9140-an-anti-ceacam5-adc-with-exatecan-payload-in-patients-with-metasta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ropeginterferon-alfa-2b-for-pre-fibrotic-primary-myelofibrosis-and-dipss-lowintermediate-risk-myelo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/anti-tumor-activity-of-bh-30643-a-novel-macrocyclic-kinase-inhibitor-in-iegfri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-preliminary-efficacy-from-a-phase-1-study-of-incb123667-a-selective-cdk2-inhibitor-in-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hospital-outcomes-in-patients-with-neuroendocrine-tumors-and-atrial-fibrillationflutter 2026-08-24 monthly 0.7 https://rjrindex.com/articles/daratumumab-plus-bortezomib-lenalidomide-and-dexamethasone-dvrd-in-patients-with-newly-diagnosed 2026-08-24 monthly 0.7 https://rjrindex.com/articles/telisotuzumab-adizutecan-abbv-400-temab-a-in-combination-with-fluorouracil-leucovorin-and-budig 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fixed-duration-subcutaneous-sc-mosunetuzumab-mosun-in-patients-with-previously-untreated-high-tu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/arc101-p1-101-a-first-in-human-phase-1-study-of-arc101-a-next-generation-t-cell-engager-tce-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-comprehensive-five-year-analysis-of-gastric-cancer-mortality-disparities-in-the-midwest-region-20 2026-08-24 monthly 0.7 https://rjrindex.com/articles/c3nira-randomized-phase-ii-study-of-carboplatin-cabazitaxel-cetrelimab-anti-pd-1-induction-follow 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-efficacy-and-safety-of-tqb2102-in-patients-with-her2-low-expressing-recurrentmetastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-comparative-outcomes-of-chemo-immunotherapy-versus-chemotherapy-in-colon-cancer-a-multi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-investigators-cis-practice-patterns-for-patients-with-hormone-receptor-positive-metastat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-neuroendocrine-tumor-related-mortality-1999-2020-a-cdc-wonder-database-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-dordaviprone-onc201-in-prospective-clinical-trials-of-adult-and-pediatric-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/navigating-the-cyber-shift-the-trends-of-electronic-health-record-ehr-engagement-in-oncology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pynnacle-phase-2-clinical-trial-of-rezatapopt-in-patients-with-advanced-solid-tumors-harboring-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-report-of-efficacy-and-safety-results-from-a-phase-2-trial-evaluating-bnt327pm8002-plus-chemo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-the-olaparib-and-azd6738-an-atmatr-inhibitor-in-isocitrate-dehydrogenase-idh 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-differences-in-serious-immune-related-adverse-events-among-cancer-patients-receiving-immune-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ib-trial-of-c019199-an-oral-tme-modulator-targeting-csf-1rddrsvegfr2-in-relapsed-or-refrac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-phase-2-study-of-the-efficacy-and-safety-of-stereotactic-body-radiation-therapy-sbrt 2026-08-24 monthly 0.7 https://rjrindex.com/articles/opera-01-a-randomized-open-label-phase-3-study-of-palazestrant-op-1250-monotherapy-vs-standard 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-rechallenge-after-trastuzumab-deruxtecan-related-interstitial-lung-disease-a-multi-instit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/camrelizumab-plus-apatinib-in-patients-with-advanced-or-refractory-chordoma-a-single-arm-open-labe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-trends-in-race-and-gender-disparities-in-the-incidence-of-osteosarcoma-leiomyosarcoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/advancing-treatment-outcomes-for-peritoneal-surface-malignancies-in-low-and-middle-income-countries 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-novel-computational-approach-for-survival-prediction-via-fusion-of-whole-slide-images-and-clinical 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimization-of-the-idisco-protocol-for-3d-reconstruction-of-cancer-samples-using-light-sheet-micros 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integration-of-a-podcast-curriculum-pc-to-improve-hematology-oncology-fellow-hof-knowledge-a-mu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/developing-and-implementing-a-fellow-driven-communication-skills-curriculum-in-hematologyoncology-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mechanism-study-of-reversing-tumor-immune-desertification-and-immunotherapy-resistance-by-low-dose-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-alterations-in-metastatic-renal-cell-carcinoma-rcc-impact-on-prognosis-and-response-to-fr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-with-iegfri-iher2i-alterations 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-treatment-with-disitamab-vedotin-monotherapy-in-patients-with-her2-overexpressing-muscle 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-safety-among-patients-with-locally-advanced-or-metastatic-urothelial-cancer-lamuc-trea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clear-cell-renal-cancer-metabolism-secrets-behind-fatty-acid-synthesis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrated-analysis-of-bulk-and-single-cell-rna-sequencing-data-to-identify-an-oxidative-phosphoryla 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-subsequent-treatment-after-combination-therapy-in-non-clear-cell-renal-cell-carcinoma-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/microbiota-proteomics-profiles-in-muscle-invasive-bladder-carcinoma-related-to-response-to-neoadjuva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-multicenter-open-label-dose-escalation-study-of-t-1201-a-small-molecule-drug-conjugate-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/avelumab-maintenance-therapy-in-patients-pts-with-advanced-urothelial-carcinoma-uc-in-japan-sub 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quantifying-patient-preferences-for-bacillus-calmette-guerin-bcg-and-pd-l1-inhibitors-in-high-ri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-treatment-outcomes-of-enfortumab-vedotin-dose-reduction-in-metastatic-bladder-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sintilimab-in-combination-with-cetuximab-and-chemotherapy-as-first-line-treatment-for-rasbraf-wild 2026-08-24 monthly 0.7 https://rjrindex.com/articles/regorafenib-response-prediction-in-metastatic-colorectal-cancer-by-a-novel-genomic-and-transcriptomi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/distribution-of-non-metastatic-and-metastatic-disease-in-incidentally-detected-and-screening-detecte 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-germline-analysis-in-young-adults-of-latin-american-descent-with-early-onset-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-factors-affecting-clinical-investigators-cis-selection-of-cdk46-inhibitors-cdkis-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-open-label-phase-1-dose-escalation-and-dose-expansion-trial-to-evaluate-the-safety-tolerability 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-cohort-study-of-the-effect-of-traditional-chinese-medicine-combined-with-western-medicine-standard 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-outpatient-car-t-therapy-in-a-community-based-medical-center 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-of-colorectal-cancer-related-mortality-among-patients-with-comorbid-type-2-diabetes-in-the-un 2026-08-24 monthly 0.7 https://rjrindex.com/articles/study-on-optimizing-serum-based-lung-cancer-diagnosis-using-a-multi-biomarker-approach 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-impact-of-lymphocytopenia-during-chemoradiation-in-locally-advanced-nsclc-patients-treated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mortality-rate-disparities-in-breast-cancer-with-obesity-insights-from-cdc-wonder-analysis-of-two-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-evaluation-of-neoadjuvant-chemotherapy-without-radiotherapy-combined-with-sintil 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pear-glio-clinical-evaluation-of-an-ai-driven-functional-precision-medicine-platform-for-therapeuti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-the-association-between-cycles-of-fertility-treatments-with-gonadotropins-and-cancer-risk 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-wider-a-phase-3b-trial-of-ribociclib-rib-endocrine-therapy-et-as-adjuvant-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/retifanlimab-with-bevacizumab-and-hypofractionated-radiotherapy-to-treat-recurrent-glioblastoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cerebrospinal-fluid-derived-ctdna-and-ctc-based-molecular-analysis-highlighting-the-sampling-proximi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-efficacy-of-intrathecal-chemotherapy-in-patients-with-leptomeningeal-metastases-a-systema 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-and-treatment-outcomes-in-head-and-neck-cancer-patients-with-brain-metastases-hnc-bm-a-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/histopathologic-and-demographic-features-of-non-small-cell-lung-cancer-in-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/using-single-cell-transcriptomics-to-reveal-cd226-upregulation-and-enhancement-of-cd19-car-t-functio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/statewide-burden-and-trends-of-liver-cancer-mortality-attributable-to-high-bmi-in-the-us-1991-2021 2026-08-24 monthly 0.7 https://rjrindex.com/articles/punch03-a-phase-ii-study-of-disitamab-vedotin-combined-with-tislelizumab-and-bacillus-calmette-guer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-lung-cancer-incidence-and-treatment-across-the-us-2019-2023 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pd-1-blockade-in-combination-with-epigenetic-therapy-to-antagonize-tumor-mesenchymal-program-and-dri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-incidence-and-impact-of-sepsis-in-patients-hospitalized-with-cholangiocarcinoma-findings-from-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-controlled-trial-comparing-conversion-surgery-with-palliative-chemotherapy-in-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-durvalumab-with-arterial-chemotherapy-in-major-portal-invaded-hepatocellular-carcinoma-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-trial-of-radium-223-dichloride-and-cabozantinib-in-patients-with-advanced-renal-cell-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/independent-validation-of-a-16-protein-test-to-assess-malignant-potential-of-small-uveal-melanocytic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/animated-patients-guide-to-melanoma-assessing-patient-understanding-shared-decision-making-and-h 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multidimensional-spatially-resolved-immunologic-hallmarks-of-response-to-neoadjuvant-immune-checkpo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-neighborhood-disadvantage-and-residential-isolation-on-cognitive-outcomes-in-cancer-surviv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-therapy-in-small-intestinal-leiomyosarcoma-a-comparative-analysis-of-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/colorectal-cancer-with-gene-fusions-navigating-the-genomic-landscape-and-treatment-selection-in-a-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-protein-energy-malnutrition-on-inpatient-mortality-healthcare-cost-and-clinical-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/factors-impacting-treatment-with-abemaciclib-endocrine-therapy-in-high-risk-early-stage-hrher2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mcm2-expression-in-locally-advanced-hormone-receptor-positive-her2-negative-hrher2-early-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/faith-trial-feasibility-and-safety-of-anlotinib-plus-benmelstobart-in-patients-with-previously-immu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/telimet-nsclc-04-a-phase-2-open-label-randomized-global-study-of-2-telisotuzumab-vedotin-regimen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-kros-101-a-small-molecule-gitr-ligand-agonist-on-t-effector-cells-t-reg-cells-and-intra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multidimensional-approach-to-improve-care-and-outcomes-for-people-with-inflammatory-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-analysis-of-outcomes-of-patients-with-colorectal-cancer-in-a-racially-diverse-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-analysis-of-mgus-risk-of-progression-and-overall-survival 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dynamic-changes-in-target-protein-expression-following-treatment-in-nsclc-simultaneous-evaluation-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/understanding-the-clinical-and-molecular-phenotype-of-cancer-of-unknown-primary-cup-with-a-lung-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-analysis-based-on-markers-of-progression-in-melanoma-a-single-center-comparison-of-surviva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/towards-a-standard-of-care-comparing-stenting-and-ligation-in-parotid-duct-management-for-oral-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-preoperative-imaging-detected-extranodal-extension-in-head-and-neck-squamous-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/kidney-disease-related-mortality-trends-and-disparities-among-patients-with-multiple-myeloma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-assessment-of-thyroiditis-in-patients-undergoing-chimeric-antigen-receptor-t-cell-therapy-a-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-burden-of-non-retinoblastoma-eye-cancer-in-204-countries-and-territories-1990-2021 2026-08-24 monthly 0.7 https://rjrindex.com/articles/egfr-missense-mutations-to-predict-skeletal-metastasis-in-lung-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dysregulation-of-dna-damage-repair-in-lung-cancer-driven-by-imtapi-loss 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neurologic-adverse-effects-associated-with-the-use-of-t-cell-engager-therapy-in-multiple-myeloma-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-effectiveness-and-safety-of-first-line-serplulimab-in-patients-with-metastatic-or-locally 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-qualitative-analysis-of-uncertainty-in-cancer-diagnosis-and-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transcriptomic-analysis-of-her2-expression-in-metastatic-breast-cancer-insights-from-a-uae-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/detecting-hotspots-of-intra-and-transchromosomal-fusions-in-liposarcomas-by-rna-sequencing 2026-08-24 monthly 0.7 https://rjrindex.com/articles/socioeconomic-disparities-in-cardio-oncology-breast-cancer-patients-from-a-single-institution 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcome-of-comprehensive-genomic-profiling-cgp-driven-personalized-treatment-in-cancer-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-of-pembrolizumab-in-advanced-head-and-neck-squamous-cell-carcinoma-a-systematic-review-and-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mortality-in-survivors-of-childhood-cancer-diagnosed-with-subsequent-thyroid-cancer-a-report-from-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-and-predictors-of-response-to-pd-l1-blockade-in-patients-with-oncogene-driver-ne 2026-08-24 monthly 0.7 https://rjrindex.com/articles/vincristine-and-topotecan-versus-carboplatin-etoposide-and-vincristine-based-chemotherapy-for-oc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-erythrocyte-antibody-conjugates-on-cancers-resistant-to-checkpoint-blockade-immunotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-mid-treatment-positron-emission-tomography-adaptive-radiotherapy-in-stage-iii-non-small-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-androgen-receptor-ligand-binding-domain-mutations-ar-lbdm-in-circulating-tumor-dna 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-satisfaction-with-telehealth-as-an-element-of-hybrid-decentralized-clinical-trials-dcts-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-impact-of-medicaid-expansion-on-outcomes-for-patients-with-gastric-cancer-in-louisian 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-evaluation-of-machine-learning-techniques-for-the-diagnosis-of-gastric-cancer-a-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/meta-analysis-and-systematic-review-of-radiomics-imaging-for-predicting-pathological-complete-respon 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiology-and-outcomes-of-sepsis-in-patients-hospitalized-with-esophageal-cancer-a-nationwide-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-time-varying-patient-reported-symptoms-and-quality-of-life-in-cancer-patients-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-comparison-of-anti-bcma-vs-anti-gprc5d-bite-therapy-in-relapsedrefractory-multiple-myelo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/elephas-01-elephas-02-and-elephas-04-multi-institutional-observational-prospective-clinical-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/medium-dose-of-tpf-chemotherapy-with-concurrent-radiotherapy-and-immunotherapy-for-locally-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlation-of-a-senescence-associated-gene-signature-with-prognosis-in-multiple-myeloma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perioperative-treatment-strategies-for-gastric-cancer-a-retrospective-real-world-study-in-china 2026-08-24 monthly 0.7 https://rjrindex.com/articles/barriers-facilitators-and-practice-patterns-for-next-generation-sequencing-testing-use-for-non-sma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-and-impact-of-incidental-pulmonary-embolism-in-solid-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-impact-of-breast-cancer-recurrence-understanding-patient-and-caregiver-perspectives-in-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/relative-depth-of-invasion-rdi-index-and-clinicopathologic-predictive-factors-for-identifying-high 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unmet-educational-needs-challenges-and-potential-benefits-in-expanding-prescriber-bases-in-oncolog 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-patient-management-practices-in-responders-to-venetoclax-for-newly-diagnosed-acute-myeloi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-significance-of-preoperational-circulating-tumor-dna-detection-in-early-stage-nsclc-using 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-lair-1-targeting-antibody-drug-conjugate-for-hematologic-cancers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-open-label-randomized-trial-of-exercise-creatine-supplementation-to-augment-the-adaptations-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-related-toxicities-of-antibody-drug-conjugates-in-breast-cancer-a-bayesian-network-meta-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/management-of-loop-electrosurgical-excision-procedure-with-positive-margins 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-neoadjuvant-chemotherapy-on-survival-outcome-in-advanced-endometrial-cancer-in-hispanic-vs 2026-08-24 monthly 0.7 https://rjrindex.com/articles/muc5ac-profiling-as-a-biomarker-for-predicting-post-recurrence-outcomes-and-guiding-precision-therap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/performance-analysis-of-artificial-intelligence-driven-convolutional-neural-network-architectures-fo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quality-of-life-in-a-phase-iii-study-of-prospective-radiation-therapy-imrt-cetuximab-for-local 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-temozolomide-and-capecitabine-chemotherapy-used-in-neuroendocrine-and-endocrine-tumours 2026-08-24 monthly 0.7 https://rjrindex.com/articles/subtype-specific-trends-in-lung-cancer-incidence-and-survival-a-seer-analysis-2004-2021 2026-08-24 monthly 0.7 https://rjrindex.com/articles/obesity-related-cancer-mortality-in-the-us-1999-2020-a-cdc-wonder-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-and-toxicity-profiles-of-bispecific-antibodies-a-nationwide-multiyear-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-imetelstat-in-transfusion-dependent-lower-risk-myelodysplastic-syndromes-a-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/from-food-deserts-to-clinical-trial-deserts-challenges-in-access-to-breast-cancer-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-inflation-adjusted-costs-and-reimbursements-for-breast-cancer-procedures-a-decade-of-decl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/results-and-recommendations-for-surveillancefollow-up-of-breast-cancer-undergoing-adjuvant-hormonot 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-onco-a-personalized-navigation-support-for-oncology-clinical-trials-in-quebec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-pro-ctcae-in-oncology-clinical-trials-insights-from-a-targeted-literature-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mammographic-screening-and-time-to-breast-cancer-diagnosis-among-immigrants-and-long-term-residents 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-drug-eluting-bead-transarterial-chemoembolization-combined-with-hepatic-arter 2026-08-24 monthly 0.7 https://rjrindex.com/articles/community-opinion-leaders-and-traditional-healers-perceptions-and-experiences-on-the-need-for-breas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-oncoquebec-an-oncology-clinical-trials-search-engine-on-clinical-trial-recruitment-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-and-predictors-of-brain-metastases-in-metastatic-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mevrometostat-an-enhancer-of-zeste-homolog-2-ezh2-inhibitor-in-combination-with-enzalutamide-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-postmastectomy-radiotherapy-on-health-related-quality-of-life-and-safety-in-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-first-line-osimertinib-in-nsclc-patients-with-egfr-mutations 2026-08-24 monthly 0.7 https://rjrindex.com/articles/connecting-clinical-trials-with-patients-using-patient-navigation-a-scoping-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neuromorphological-effects-of-simultaneous-exercise-during-neo-adjuvant-chemotherapy-in-breast-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-prostate-cancer-pca-outcomes-after-primary-prostatectomy-among-latinos 2026-08-24 monthly 0.7 https://rjrindex.com/articles/does-the-surgeons-learning-curve-impact-pentafecta-outcomes-in-radical-prostatectomy-a-systematic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/psma-pet-as-a-way-to-choose-oligometastatic-patients-for-intermittent-androgen-deprivation-extended 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-radiation-dose-in-multi-isocentric-volumetric-arc-based-total-body-irradiation-on-oncologi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/community-based-patient-navigation-and-preventative-care-among-women-surviving-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-in-major-adverse-cardiovascular-and-cerebrovascular-events-outcomes-among-hospita 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparing-impact-of-treatment-before-or-after-surgery-in-patients-with-stage-ii-iiib-resectable-non 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-genomic-profiling-of-matched-ctdna-and-tissue-from-patients-with-less-common-cancers-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-nivolumab-plus-ipilimumab-for-patients-with-pre-treated-type-b3-thymoma-and-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-chemotherapy-with-gemcitabine-plus-cisplatin-followed-by-radical-liver-resection-versus 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adherence-to-repeat-screening-for-colorectal-cancer-using-the-multi-target-stool-dna-test-real-worl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-first-in-human-phase-iii-study-of-gfh375-a-highly-selective-and-potent-oral-kras-g12d-inhibitor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tropion-lung14-a-phase-3-study-of-osimertinib-datopotamab-deruxtecan-dato-dxd-as-first-line-1l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-ctdna-monitoring-of-erher2-high-risk-breast-cancer-during-adjuvant-endocrine 2026-08-24 monthly 0.7 https://rjrindex.com/articles/age-related-macular-degeneration-in-individuals-with-clonal-hematopoiesis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/subgroup-analysis-of-the-phase-2-part-of-the-ringside-phase-23-trial-of-varegacestat-for-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-of-mechanisms-driving-cd20-loss-in-patients-with-relapsed-or-refractory-large-b-cel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-of-infections-cardiac-events-neurological-toxicity-and-cytokine-response-syndrome-crs 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-breast-cancer-screening-for-the-brazilian-unified-health-system-sus-a-warning-of-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-low-dose-dasatinib-50mg-in-chronic-myeloid-leukemia-chronic-phase-cml-cp-in-lmic-ar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-i-dose-escalation-study-to-evaluate-safety-and-feasibility-of-neoadjuvant-camrelizumab-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-branched-chain-amino-acid-metabolic-interactions-between-hibadh-tumor-cells-and-bcat1-ma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-outcomes-of-car-t-cell-therapy-in-dlbcl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-analysis-of-ctdna-mrd-and-mvi-in-predicting-postoperative-recurrence-of-hepatocellular-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-status-of-medical-oncology-in-china-de-smog-a-nationwide-questionnaire-based-surv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploratory-ctdna-analyses-for-the-evoke-1-study-in-metastatic-non-small-cell-lung-cancer-mnsclc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-tumor-microenvironment-profiling-at-single-cell-level-in-patients-with-locally-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/retracted-randomized-trial-of-relevance-of-time-of-day-of-immunochemotherapy-for-progression-free-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/her2dx-genomic-test-in-her2-positive-breast-cancer-treated-with-15-weeks-of-neoadjuvant-paclitaxel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-class-pd-1il-2-bispecific-antibody-ibi363-in-patients-pts-with-advanced-immunotherapy-tr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/discovery-of-potent-degraders-of-pan-kras-based-on-a-novel-kras-binder 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quantitative-pre-treatment-assessment-of-trastuzumab-deruxtecan-t-dxd-antibody-target-her2-and-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-findings-from-a-multi-institutional-quality-study-using-cfir-to-explore-gaps-challenges 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cadonilimab-in-combination-with-ivonescimab-and-chemotherapy-as-first-line-1l-therapy-in-patients-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/giredestrant-g-with-atezolizumab-atezo-andor-abemaciclib-abema-in-patients-pts-with-erhe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/initial-phase-1-dose-escalation-data-for-emiltatug-ledadotin-emi-le-a-novel-b7-h4-directed-dolasy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/decoding-the-response-and-resistant-features-to-the-claudin182-specific-car-t-cell-ct041-in-gastric 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-co-inheritance-of-kmt2c-germline-mutations-on-the-phenotype-of-msi-lmss-lynch-syndrome-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-5-year-remission-and-survival-after-treatment-with-ciltacabtagene-autoleucel-cilta-cel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimizing-frontline-therapy-for-diffuse-large-b-cell-lymphoma-dlbcl-in-older-adults-a-glofitamab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sasanlimab-in-combination-with-bacillus-calmette-guerin-bcg-in-bcg-naive-high-risk-non-muscle-inv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-longitudinal-immune-cell-monitoring-in-patients-with-extensive-stage-small-cell-lung-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/origami-2-a-randomized-phase-3-study-of-amivantamab-vs-cetuximab-both-in-combination-with-folfox 2026-08-24 monthly 0.7 https://rjrindex.com/articles/msln-and-cldn182-dual-target-car-t-therapy-enhancing-cancer-treatment-with-improved-efficacy-and-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beamion-pantumor-1-a-phase-ii-multicenter-multicohort-open-label-trial-to-evaluate-the-efficacy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pembrolizumab-in-pediatric-participants-with-relapsed-or-refractory-microsatellite-instability-high 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inotch1i-mutation-and-survival-analysis-of-tislelizumab-in-advanced-or-meta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-zipalertinib-in-nsclc-patients-with-egfr-exon-20-insertion-mutations-who-received-prior 2026-08-24 monthly 0.7 https://rjrindex.com/articles/major-adverse-cardiovascular-events-mace-in-cancer-patients-treated-with-tirzepatide-compared-to-g 2026-08-24 monthly 0.7 https://rjrindex.com/articles/keynote-859-45-year-median-follow-up-of-pembrolizumab-plus-chemotherapy-for-previously-untreated-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/debio-0123-a-highly-selective-wee1-inhibitor-in-combination-with-carboplatin-c-and-etoposide-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-patients-with-concurrent-chronic-lymphocytic-leukemia-and-non-small-cell-lung-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/descriptive-analysis-of-the-pcp-onc-cares-program-integrating-primary-care-into-oncology-in-a-value 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breast-cancer-detection-using-a-realtime-breath-analyzer-a-pilot-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiological-analysis-of-gastric-cancer-in-uzbekistan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/alectinib-in-children-and-adolescents-with-solid-or-cns-tumors-harboring-alk-fusions-a-data-update 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rna-based-fusion-ngs-panel-testing-for-the-improved-classification-of-soft-tissue-sarcomas-a-retros 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-of-post-transplant-survival-in-patients-with-newly-diagnosed-acute-myeloid-leukemia-recei 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-combination-therapy-of-ponatinib-and-blinatumomab-in-philadelphia-chromosome 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characteristics-and-concomitant-congenital-abnormalities-among-newborns-with-cancer-a-population-le 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-single-center-prospective-randomized-controlled-trial-of-tislelizumab-combined-with-platinum-con 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-safety-and-efficacy-of-tislelizumab-with-or-without-chemotherapy-versus-chemotherapy-alo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/single-cell-analysis-and-histopathological-evaluation-of-tertiary-lymphoid-structures-and-associatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-socioeconomic-and-demographic-factors-on-treatment-related-time-intervals-in-oral-cavity-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-results-from-a-phase-iia-trial-of-apg-157-in-oral-cavity-and-oropharyngeal-dysplasia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-based-classification-of-laryngeal-dysplasia-and-lymphocytic-activity-quantification-from-routine 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breast-cancer-recurrence-and-mortality-among-survivors-of-childhood-cancer-a-report-from-the-childh 2026-08-24 monthly 0.7 https://rjrindex.com/articles/advancing-therapeutic-target-discovery-with-multi-omics-effect-of-unbiased-phosphoproteomic-and-met 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-association-of-ctdna-with-recurrence-in-patients-with-stage-ii-iv-colorectal-cancer-the-v-corre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-profiling-of-metastatic-lung-squamous-cell-carcinoma-mlusc-to-identify-patients-with-dif 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lymphatic-mapping-to-the-inguinal-region-in-patients-with-lower-extremity-melanoma-undergoing-radica 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-populational-change-in-prognosis-of-patients-diagnosed-with-locally-advanced-melanoma-last-glimps 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-egfr-tkis-treatment-challenge-in-nsclc-changes-in-survival-after-covid-19-infection 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-of-feeding-tube-utilization-in-base-of-tongue-adenoid-cystic-carcinoma-treated-with-neutron 2026-08-24 monthly 0.7 https://rjrindex.com/articles/systematic-review-and-meta-analysis-of-neoadjuvant-anti-pd-l1-inhibitors-in-head-and-neck-squamous 2026-08-24 monthly 0.7 https://rjrindex.com/articles/waterpipe-smoking-as-deregulator-of-rna-m6a-modification-and-promotor-of-epithelial-mesenchymal-tran 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ethnic-and-racial-disparities-in-sebaceous-gland-carcinoma-of-the-eyelid-a-seer-database-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/body-mass-index-and-somatic-variants-in-biliary-tract-cancers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparing-mortality-risk-in-patients-with-malignant-melanoma-and-type-2-diabetes-mellitus-treated-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographic-and-clinical-disparities-in-early-mortality-of-metastatic-melanoma-patients-a-seer-base 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-based-classification-of-cancer-types-using-genomic-profiling-data-from-the-australi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improved-detection-of-circulating-tumor-dna-in-patients-with-leiomyosarcoma-with-fragment-size-restr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-disitamab-vedotin-combination-therapy-in-her2-positive-advanced-gynecological 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perceptions-of-vietnamese-women-regarding-hpv-self-collection-a-cross-sectional-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utilizing-circulating-tumor-dna-methylation-levels-to-predict-pathological-and-radiological-response 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-trastuzumab-deruxtecan-in-hr-negative-her2-low-advanced-breast-cancer-a-real 2026-08-24 monthly 0.7 https://rjrindex.com/articles/platinum-or-non-platinum-therapy-in-post-olaparib-recurrent-ovarian-cancer-analysis-in-matched-coho 2026-08-24 monthly 0.7 https://rjrindex.com/articles/thymidine-kinase-activity-as-a-prognostic-tool-in-blood-samples-of-primary-ovarian-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-findings-from-the-alva-epro-platform-pilot-study-a-novel-approach-to-collecting-quality 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-disparities-in-survival-among-stage-iii-iv-melanoma-patients-in-the-era-of-immunotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breast-cancer-survivors-perspectives-on-a-clinical-decision-tool-to-facilitate-individualized-exerc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/aging-and-global-cancer-burden-a-population-based-comparative-situation-analysis-and-predictions-fr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-the-impact-of-race-ethnicity-and-bmi-on-neoadjuvant-hormonal-treatment-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mevrometostat-in-combination-with-enzalutamide-for-androgen-receptor-pathway-inhibitor-arpi-naive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bothersome-hot-flashes-following-relugolix-and-stereotactic-body-radiotherapy-for-localized-prostate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-ph-like-b-lineage-acute-lymphoblastic-leukemia-in-the-era-of-novel-therapies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cytomolecular-mechanisms-of-relapse-after-frontline-flt3-inhibitor-flt3i-based-therapy-in-flt3-mut 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identifying-profiles-and-mapping-the-patient-journey-in-japan-with-a-large-scale-digital-survey-of-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reflex-precision-oncology-consultation-to-increase-comprehensive-genomic-profiling-rates-in-non-smal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-clonal-hematopoiesis-ch-of-short-variants-svs-detected-in-liquid-biopsies-lbx-in-gen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-the-availability-of-radiotherapy-services-across-nigeria 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-food-insecurity-and-financial-hardship-with-healthcare-utilization-among-adults-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-177lut-psma-in-metastatic-castrate-resistant-prostate-cancer-in-the-post-chemotherapy-setting 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trajectories-of-clinical-encounters-among-long-term-lung-cancer-survivors-a-seer-medicare-cluster-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-alcohol-dependence-on-the-efficacy-of-immune-checkpoint-inhibitors-a-comprehensive-real-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/living-beyond-cancer-the-long-term-impact-of-breast-cancer-diagnosis-on-cognitive-function 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-adrenocortical-cancer-mortality-in-the-us-from-1999-to-2020-regional-demographic-and-geo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-patients-with-esophageal-and-gastric-carcinomas-at-a-safety-net-healthcare-system 2026-08-24 monthly 0.7 https://rjrindex.com/articles/how-much-does-your-medication-cost-assessing-patient-attitudes-towards-the-costs-of-oncology-med 2026-08-24 monthly 0.7 https://rjrindex.com/articles/understanding-place-based-inequities-in-lung-cancer-care-trends-in-geographic-hotspots-of-late-stag 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-a-digital-health-platform-in-improving-psa-and-blood-pressure-levels-in-members-living-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrative-oncology-interest-in-persons-with-a-cancer-diagnosis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/itp53i-multihit-mutations-in-142-patients-with-mpn-or-aml-comparative-analysis-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-validation-of-six-androgen-production-uptake-and-conversion-genes-apuc-6-in-the-chaar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unveiling-the-unheard-narratives-integrating-narrative-medicine-into-electronic-medical-records-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-pregnancy-history-and-recency-of-childbirth-on-long-term-outcomes-in-young-patients-with-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differences-in-insurance-status-among-asian-americans-with-cancer-a-disaggregated-analysis-by-ethni 2026-08-24 monthly 0.7 https://rjrindex.com/articles/financial-toxicity-in-cancer-care-experience-from-a-tertiary-care-cancer-center 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-brain-metastases-on-survival-rates-in-patients-with-metastatic-testicular-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identifying-delivery-of-palliative-care-in-administrative-billing-claims-data-a-scoping-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-recist-criteria-in-resource-limited-settings-guatemala-experience 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chemotherapy-induced-peripheral-neuropathy-in-breast-cancer-prevalence-and-predictors-in-an-indian 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diversity-and-representation-in-head-and-neck-cancer-trials-following-the-2010-affordable-care-act 2026-08-24 monthly 0.7 https://rjrindex.com/articles/star-01-a-randomized-phase-iii-clinical-trial-comparing-pd-1-combined-with-apatinib-and-soxpd-1-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-outcomes-in-patients-pts-with-renal-impairment-in-the-phase-3-dreamm-7-and-dre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-lymphocyte-count-dynamics-on-the-predictive-value-of-tumor-mutational-burden-tmb-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/travel-impacts-for-patients-with-cancer-living-in-the-rural-mountain-west 2026-08-24 monthly 0.7 https://rjrindex.com/articles/are-patients-satisfied-with-the-information-in-an-informed-consent-form-questionnaire-based-study-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fusing-quality-improvement-and-education-frameworks-to-reduce-delays-in-tumor-genotyping-at-communit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-nationwide-trends-in-multiple-myeloma-mm-autologous-stem-cell-transplants-ascts-chim 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-iii-randomized-controlled-trial-comparing-palliative-stereotactic-body-radiotherapy-vs-pall 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-adjuvant-anti-pd-1-antibodies-and-interferon-in-patients-with-nail-apparatus-melanoma-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-outcomes-after-discontinuation-of-retifanlimab-in-patients-with-advanced-or-metastatic-mer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/financial-toxicity-and-employment-outcomes-in-people-with-melanoma-receiving-adjuvant-therapies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-elinzanetant-on-sleep-disturbances-and-quality-of-life-in-women-undergoing-adjuvant-endocr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pd-l1-as-a-biomarker-in-gastric-cancer-concordance-between-ihc-methods 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-supportive-and-palliative-care-referral-at-a-comprehensive-cancer-center-a-seven-year-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-nalirifox-liposomal-irinotecan-5-fluorouracil-leucovorin-and-oxaliplatin-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-the-mutational-and-molecular-profile-of-pancreatic-cancer-a-comprehensive-genomics-approa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/functional-role-of-gli2-in-cancer-associated-fibroblasts-for-modulation-of-the-fibrotic-tumor-microe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-importance-of-algorithms-when-determining-homologous-recombination-deficiency-status-in-ovarian 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-pancreatic-cancer-mortality-in-older-adults-with-diabetes-mellitus-in-the-united-states-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perceptions-of-work-stress-burnout-and-burnout-management-strategies-among-oncologists 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interim-open-label-phase-1-results-of-misetionamide-gp-2250-a-small-molecule-antineoplastic-targe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perioperative-immunotherapy-for-stage-ii-iii-nsclc-patients-a-retrospective-real-world-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lung-cancer-combined-with-interstitial-lung-disease-controversial-role-of-preexisting-hypertension 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pregnancy-and-infant-outcomes-post-cd19-directed-car-t-therapy-tisagenlecleucel-tisa-cel-andor-h 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-axicabtagene-ciloleucel-axi-cel-for-the-treatment-of-relapsedrefractory-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/awareness-knowledge-and-attitudes-toward-breast-cancer-polygenic-risk-scores-for-precision-prevent 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neuro-oncology-anywhere-242-pilot-study-evaluating-telehealth-and-in-person-assessments-in-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-evolution-of-breast-cancer-genetic-testing-comparative-outcomes-of-nccn-asco-and-universal-gu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-significance-of-germline-cftr-mutations-in-pancreatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-utility-of-dna-methylation-signatures-in-tissue-and-biofluids-for-lung-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-pediatric-obesity-related-cancers-in-the-united-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-tumoral-molecular-landscape-of-long-term-survivors-with-isocitrate-dehydrogenase-wildtype-gliobl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-endoscopic-treatment-with-mucosal-resection-radiofrequency-ablation-and-cry 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-clinical-review-of-a-novel-blood-test-use-in-rural-alabama-for-multi-cancer-detection-analyzing-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nci-10479-a-phase-i-dose-escalation-expansion-trial-of-sunitinib-malate-plus-lutetium-lu-177-dota 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-evidence-of-survival-in-locally-advanced-esophago-gastric-cancers-treated-with-perioperat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-and-ethnic-disparities-in-neuroblastoma-incidence-and-mortality-a-systematic-review-and-meta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/australasian-gastro-intestinal-trials-group-agitg-stopnet-a-randomized-study-of-cessation-of-soma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-dose-dense-anthracycline-and-cyclophosphamide-in-combination-with-carboplatin-paclitaxe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-outcomes-of-esophageal-cancer-hospitalizations-a-trend-analysis-2008-2021 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-effectiveness-and-safety-of-neoadjuvant-chemotherapy-in-combination-with-pembrolizumab-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-data-on-pathological-complete-response-and-outcomes-in-hormone-receptor-positive-breast-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-role-of-consolidative-chest-radiotherapy-after-chemo-immunotherapy-in-extensive-stage 2026-08-24 monthly 0.7 https://rjrindex.com/articles/codex2-a-novel-scoring-system-for-cdx2-loss-in-colon-cancer-unraveling-prognostic-insights-and-ther 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ryz101-sup225sup-ac-dotatate-in-patients-with-estrogen-receptor-posi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-rw-study-to-identify-disparities-in-outcomes-for-patients-pts-with-early-stage-resect 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-demographic-and-socioeconomic-factors-on-survival-outcomes-in-patients-with-waldenstrom-ma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/does-early-versus-late-initiation-of-immunotherapy-in-extensive-stage-small-cell-lung-cancer-affect 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-trastuzumab-and-trastuzumab-adjunct-chemotherapy-her2-amplified-colorectal-cancer-a-sys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/deciphering-colorectal-cancer-progression-through-integrative-epigenomic-analysis-for-precision-ther 2026-08-24 monthly 0.7 https://rjrindex.com/articles/peripheral-myeloid-derived-suppressor-cell-as-a-biomarker-for-diagnosing-and-predicting-the-treatmen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transforming-lung-cancer-care-for-the-underserved-real-world-results-of-sbrt-in-a-safety-net-system 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-observational-study-of-fruquintinib-in-combination-with-irinotecan-and-capecitabine-as-se 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-radiomic-features-on-prediction-of-progression-free-survival-in-patients-with-non-small-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-the-estrogen-receptor-alpha-esr1-and-aromatase-expression-in-non-small-cell-lu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/web-based-analysis-of-multiparameter-cytometry-datasets 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-12-open-label-study-evaluating-the-efficacy-safety-and-pharmacokinetics-of-luveltamab-ta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/doxorubicin-based-chemotherapy-vs-gemcitabinedocetaxel-in-uterine-leiomyosarcoma-ulms 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cardiovascular-and-oncologic-outcomes-of-nivolumab-ipilimumab-vs-pembrolizumab-in-malignant-melan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-molecular-analysis-of-phase-ii-trial-of-nivolumab-in-patients-with-recurrent-or-metast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-the-combination-of-regorafenib-avelumab-in-patients-with-non-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pd-1-inhibitors-combined-with-radiotherapy-and-gm-csf-sequentially-followed-by-il-2-regimen-in-adva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cytokine-mediated-hypersensitivity-reactions-to-carboplatin-in-early-triple-negative-breast-cancer-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/should-we-treat-tp53-mutated-high-risk-myeloid-neoplasms-in-older-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/master-protocols-in-oncology-opportunities-challenges-and-strategic-approaches-to-design-and-impl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-detection-of-ovarian-cancer-an-accurate-high-throughput-extracellular-vesicle-test 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cost-analysis-of-pre-treatment-dihydropyrimidine-dehydrogenase-idpydi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-subtyping-and-insights-into-sarcoma-biology-and-prognosis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improvemf-update-phase-11b-trial-of-imetelstat-imeruxolitinib-rux-in-patients-pts-with-inte 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ceralasertib-cerala-olaparib-ola-in-patients-pts-with-homologous-recombination-repair-hrr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/telisotuzumab-adizutecan-abbv-400-temab-a-a-c-met-protein-targeting-antibody-drug-conjugate-adc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/arches-5-year-follow-up-overall-survival-os-analysis-of-enzalutamide-enza-plus-androgen-depriva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/db-1311bnt324-a-novel-b7h3-adc-in-patients-with-heavily-pretreated-castrate-resistant-prostate-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-survival-outcomes-and-predictors-of-benefit-from-ovarian-function-suppression-in-premenopaus 2026-08-24 monthly 0.7 https://rjrindex.com/articles/db-1310-a-her3-targeted-adc-in-pts-with-advanced-solid-tumors-preliminary-results-from-the-phase 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-patients-treated-with-tarlatamab-in-extensive-stage-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/daratumumab-bortezomib-lenalidomide-and-dexamethasone-dvrd-vs-vrd-in-transplant-ineligible-ti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-3-randomized-study-of-asp-1929-photoimmunotherapy-in-combination-with-pembrolizumab-versus-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-adherence-to-cdk46-inhibitors-in-breast-cancer-through-remote-therapeutic-monitoring-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-economics-of-cancer-immunotherapy-a-five-year-medicare-b-expenditure-analysis-of-checkpoint-inh 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updates-to-core-008-a-phase-2-multi-arm-multi-cohort-study-to-evaluate-intravesical-cretostimogene 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cetuximab-plus-dalpiciclib-in-patients-with-hpv-negative-anti-pd-1-resistant-recurrent-or-metastati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-quality-improvement-initiative-to-improve-fertility-counseling-and-referral-procedures-for-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-inflammation-with-depression-in-pancreatic-ductal-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/performance-of-sup177sup-lu-psma-iampt-for-rlt-in-mcrpc-first-prospe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-and-clinician-expert-perspectives-on-the-impactful-symptoms-of-head-and-neck-squamous-cell-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dupilumab-for-bullous-pemphigoid-induced-by-immune-checkpoint-inhibitors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-off-label-mapk-inhibitor-therapy-in-children-with-severerefractory-langerhans-cell-histio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dipeptidyl-peptidase-9-dpp9-depletion-from-hepatocytes-in-mice-to-retard-tumour-growth-increase-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-assessment-of-colitis-related-adverse-events-in-multiple-myeloma-patients-treated-with-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-open-label-study-to-improve-compliance-and-time-of-treatment-after-obtaining-complete-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-clinical-trial-of-autologous-t-cells-genetically-engineered-with-a-chimeric-receptor-to-targ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-predictors-of-brain-metastases-in-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-longitudinal-analysis-of-social-networks-and-patient-reported-outcomes-among-young-adult-cancer-su 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-of-administration-of-cue-101-a-novel-hpv16-e7-phla-il2-fc-fusion-protein-before-curative-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/stratification-of-vulvar-squamous-cell-carcinoma-vscc-by-hpv-and-p53-status-to-guide-excision-cct 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-randomized-study-of-chemoimmunotherapy-with-or-without-eflornithine-dfmo-in-relapsedref 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interim-safety-and-efficacy-data-of-sup212sup-pbvmt01-in-mc1r-expres 2026-08-24 monthly 0.7 https://rjrindex.com/articles/second-line-askb589-plus-chemotherapy-for-advanced-gastric-or-gastroesophageal-cancers-results-from 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-trends-in-mortality-of-pancreatic-cancer-in-adults-aged-70-and-older-across-204-nations-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-cadonilimab-in-recurrentmetastatic-solid-tumors-including-ici-treated-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-efficacy-of-mutant-selective-pi3ka-inhibitor-rly-2608-in-combination-with-fulvestrant-in-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/secure-a-dose-escalationexpansion-study-to-assess-the-anti-tumor-efficacy-of-sup67 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-artificial-intelligences-ai-clinical-reasoning-with-skin-cancer-multiple-choice-questi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-dose-expansion-study-of-dsp107-a-first-in-class-bi-specific-4-1bb-t-cell-engager-with-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-of-induction-aumolertinib-followed-by-aumolertinib-and-concurrent-radiotherapy-rt-in-unre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/indirect-comparison-of-linvoseltamab-versus-elranatamab-for-triple-class-exposed-tce-relapsedrefr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1b2-safety-lead-in-and-dose-expansion-trial-of-ivosidenib-plus-durvalumab-and-gemcitabine 2026-08-24 monthly 0.7 https://rjrindex.com/articles/proposed-changes-to-the-pathologic-staging-for-colon-cancer-cc-ajcc-colon-cancer-expert-panel-aj 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breast-cancer-in-chronic-lymphocytic-leukemia-patients-characteristics-and-survival-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/carfilzomib-lenalidomide-and-dexamethasone-krd-as-maintenance-therapy-after-autologous-stem-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-study-of-the-ox40-agonist-bgb-a445-with-or-without-tislelizumab-an-anti-pd-1-monoclonal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hypoxia-responsive-cea-car-t-cells-therapy-for-relapsed-or-refractory-non-small-cell-lung-cancer-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-of-pre-cancerous-advanced-adenomas-of-the-colon-in-long-distance-runners 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-osemitamab-tst001-plus-nivolumab-and-capox-for-advanced-ggej-cancer-transtar102-upd 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-checkpoint-inhibition-in-ebv-associated-gastric-cancer-a-multi-center-international-retrospe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-the-role-of-the-oral-microbiome-in-saliva-sputum-bronchoalveolar-fluid-and-tissue-tumor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dual-inhibition-of-her2-and-vegf-pathways-in-breast-cancer-a-meta-analysis-of-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/maintaining-momentum-in-cancer-health-equity-examining-native-hawaiian-and-pacific-islander-us-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/eon-phase-ii-trial-of-etigilimab-mph313-in-combination-with-nivolumab-in-patients-with-recurrent 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trodelvy-use-in-advanced-triple-negative-breast-cancer-in-australia-tracie-study-design-and-inter 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-weight-change-and-bmi-as-prognostic-markers-of-survival-outcomes-in-sacituzumab-govite 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathological-features-and-outcomes-of-patients-with-gastrointestinal-stromal-tumor-at-institu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-detection-of-renal-cell-carcinoma-a-novel-cfdna-fragmentomics-based-liquid-biopsy-assay 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-burden-of-non-burkitt-non-hodgkins-lymphoma-nhl-1990-2021 2026-08-24 monthly 0.7 https://rjrindex.com/articles/refining-intermediate-risk-ir-stratification-in-patients-pts-with-metastatic-renal-cell-carcinom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/paraneoplastic-syndromes-in-non-small-cell-lung-carcinoma-a-systematic-review-of-case-reports-and-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-time-to-neoadjuvant-treatment-initiation-tti-for-resectable-non-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-first-in-human-multi-center-phase-12-study-of-a-selective-fgfr23-inhibitor-cgt4859-in-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-in-rectal-cancer-with-yptnm-vs-ptnm-staging-after-neoadjuvant-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-and-barriers-of-second-line-therapy-selection-in-hrher2-metastatic-breast-cancer-among-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-characterization-of-stas-in-stage-1-egfr-mutated-nsclc-and-prognostic-implications 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-edil3-cafs-on-lymph-node-metastasis-through-disruption-of-lymphatic-endothelial-barriers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/retrospective-analysis-of-the-efficacy-and-safety-of-disitamab-vedotin-rc48-in-chinese-patients-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gauging-sustainable-cancer-ca-prevention-in-lynch-syndrome-ls-attitudes-toward-dietary-interven 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-for-colon-adenocarcinoma-in-a-hospital-based-cancer-registry-in-cali-colombia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-validation-of-a-multi-feature-immune-scoring-prognostic-model-for-stage-ii-and-iii-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-12-studies-of-dzd8586-in-cllsll-patients-after-covalent-or-non-covalent-btk-inhibitors-and-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/triplet-therapy-with-braf-inhibitor-anti-egfr-agent-and-mek-inhibitor-in-v600e-braf-mutant-colorec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-liposomal-irinotecan-combined-with-cadonilimab-as-second-line-treatment-for-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-dose-optimization-update-with-ezh2ezh1-inhibitor-tulmimetostat-in-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-immunotherapy-in-hormone-receptor-positive-breast-cancer-a-systematic-review-and-meta-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-integrative-analysis-of-circulating-and-tumor-microenvironment-tme-determinants-of-patient-resp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/stratified-analysis-of-mesothelioma-mortality-a-21-year-atlas-of-trends-and-demographic-shifts-in-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-predictors-of-response-to-immunotherapy-in-patients-with-extensive-stage-small-cell-lung-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radiotherapy-followed-by-systemic-therapy-and-tislelizumab-in-mss-rectal-cancer-with-liver-metastase 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-with-statins-and-cdk46-inhibitors-in-patients-with-metastatic-hrher2-breast-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/keeping-an-eye-on-immune-effector-cell-associated-neurotoxicity-syndrome-icans-outcomes-and-predi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-cancer-system-characteristics-and-global-pan-cancer-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/obesity-and-cancer-in-america-from-declining-mortality-to-emerging-challenges 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-response-bias-in-recist-11-impact-on-non-target-lesion-assessment-in-oncology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sunburst-plot-a-tool-for-interpretation-and-prediction-of-inter-reader-variability-relationships-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/guide-t-a-three-tier-markmap-driven-platform-for-streamlined-breast-cancer-trial-navigation-and-im 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicogenomic-landscape-and-outcomes-of-metastatic-colorectal-cancer-patients-with-pathogenic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-body-mass-index-on-immunotherapy-outcomes-and-complications-in-solid-tumor-patients-a-rea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-the-association-of-blood-to-tissue-tumor-mutation-burden-tmb-ratio-with-overall-surv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographic-and-regional-trends-in-multiple-myeloma-and-cardiovascular-disease-related-mortality-amo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dabrafenib-and-trametinib-vs-anti-pdl1-for-the-adjuvant-treatment-of-locally-advanced-braf-mutant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-iii-randomized-trial-of-radiotherapy-optimization-for-low-risk-her2-positive-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-of-adherence-to-an-onoff-regimen-for-lenalidomide-in-patients-with-multiple-myeloma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/melanoma-and-pregnant-women-a-systematic-review-and-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-study-of-atezolizumab-with-carboplatin-plus-pemetrexed-followed-by-maintenance-atezolizumab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ctdna-tumor-fraction-tf-to-predict-response-to-nivolumab-in-recurrent-or-metastatic-rm-head-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/is-one-year-enough-extended-adjuvant-dabrafenib-plus-trametinib-for-chinese-patients-with-resected 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-in-early-stage-cutaneous-desmoplastic-melanoma-a-national-cancer-database-analysi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-laryngeal-cancer-incidence-and-mortality-a-comprehensive-analysis-of-long-term-and-recent 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-factors-and-outcomes-in-patients-with-hematological-malignancies-developing-therapy-relat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-gastrostomy-and-clinical-outcomes-including-septicemia-weight-loss-mortality 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-ttmv-hpv-dna-testing-for-surveillance-in-hpv-head-and-neck-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-related-liver-toxicity-management-and-outcomes-in-ici-treated-patients-with-advanced-or-met 2026-08-24 monthly 0.7 https://rjrindex.com/articles/liquid-biopsy-ngs-as-a-longitudinal-follow-up-tool-in-the-clinical-management-of-oscc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-application-of-the-painvision-system-for-quantitative-assessment-of-chemotherapy-induced-pe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/antitumor-effect-of-prag-therapy-in-a-triple-negative-breast-cancer-model 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-effectiveness-and-healthcare-utilization-of-nivolumab-for-recurrent-andor-metastatic-squ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multiomic-profiling-of-lrrc15-in-triple-negative-breast-cancer-tnbc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-germline-homologous-recombination-deficiency-mutations-with-her2-status-conversion-fr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-low-dose-rapamycin-on-the-therapeutic-response-to-radio-immunotherapy-in-hepatocellular-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-differences-in-peripheral-neuropathy-and-associated-supportive-treatment-in-breast-cancer-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-assisted-exploration-of-novel-non-invasive-biomarkers-of-ici-therapy-response 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-12-open-label-first-in-human-study-of-the-anti-gpc3-t-cell-engager-sar444200-in-patients-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-immunotherapy-or-antiangiogenic-agents-based-treatment-strategies-versus-chem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/understanding-the-molecular-landscape-of-rare-tumors-through-the-ccdi-cog-molecular-characterization 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-smox-gene-expression-with-immune-checkpoint-therapy-response-in-patients-with-non-sma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-applicability-of-axillary-surgery-omission-in-real-world-breast-cancer-patients-insi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-3-study-of-177lu-rosptamab-plus-standard-of-care-vs-standard-of-care-alone-in-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-sequences-and-outcomes-in-patients-with-mcrpc-in-us-urology-clinics 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-value-of-integrating-urology-and-oncology-real-world-data-for-understanding-prostate-cancer-mana 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dosing-decitabine-and-venetoclax-for-terminal-differentiation-to-improve-outcomes-in-tp53-mutant-mds 2026-08-24 monthly 0.7 https://rjrindex.com/articles/infectious-complications-in-relapsedrefractory-multiple-myeloma-patients-treated-with-bispecific-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-genomic-alterations-on-outcomes-in-patients-with-metastatic-castration-resistant-prostate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/modulation-of-enhancer-of-zeste-homolog-2-ezh2-pharmacodynamic-pd-markers-and-tumor-gene-express 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-ipteni-deletion-itmprss2i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prostate-adenocarcinoma-to-neuroendocrine-tumor-a-therapy-driven-response 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tlr9-agonists-as-a-potential-therapeutic-option-for-b-all-patients-with-low-p53-expression 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dyslipidemia-in-long-term-survivors-of-testicular-germ-cell-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-emerging-role-of-pharmacists-in-optimizing-therapeutic-substitutions-within-the-us-oncology-netw 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-pre-biopsy-steroids-on-diagnostic-yield-in-diffuse-large-b-cell-lymphoma-dlbcl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/estimation-of-population-attributable-fractions-based-on-integrated-global-cancer-incidence-data-19 2026-08-24 monthly 0.7 https://rjrindex.com/articles/leveraging-high-variant-allele-frequencies-vaf-of-dna-damage-repair-ddr-mutations-muts-in-liqu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/systemic-mastocytosis-statistics-and-impact-of-secondary-malignancy-on-survival 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-factors-rf-for-brain-metastases-bm-in-patients-pts-with-metastatic-breast-cancer-mbc-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-split-dose-lymphocyte-adjusted-rabbit-atg-in-allogeneic-stem-cell-transplant-recipients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/accelerating-phase-2-clinical-development-with-real-world-data-rwd-an-external-control-arm-eca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-palliative-chemotherapy-in-hospitalized-patients-with-advanced-solid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utilization-and-timeliness-of-next-generation-sequencing-testing-for-patients-with-resected-or-metas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prospective-assessment-of-health-related-quality-of-life-in-early-phase-clinical-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spillover-effects-of-medicaid-expansion-on-insurance-coverage-diagnosis-and-survival-among-low-inc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/delivery-of-b7h3-targeted-car-t-cells-in-injectable-silk-hydrogels-and-effects-on-the-efficacy-in-tr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/donafenib-combined-with-capecitabine-for-postoperative-adjuvant-therapy-of-biliary-malignant-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multicenter-real-world-study-of-trastuzumab-combined-with-pirotinib-or-pertuzumab-as-a-neoadjuvant-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transcatheter-arterial-chemoembolization-plus-donafenib-and-sintilimab-for-unresectable-hepatocellul 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tocilizumab-in-fibrolamellar-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcome-of-localized-therapy-for-residual-or-recurrent-oligo-melanoma-or-renal-cell-cancer-rcc-fol 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-observational-study-on-the-usage-of-glp-1-in-breast-cancer-patients-in-the-us 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-role-of-adar1-mediated-a-to-i-rna-editing-and-non-editing-functions-in-radioresistance-of-esopha 2026-08-24 monthly 0.7 https://rjrindex.com/articles/landscape-of-geriatric-oncology-in-switzerland-results-from-a-nationwide-survey 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-er-staining-patterns-and-heterogeneity-of-er-positive-her2-negative-breast-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-risk-stratified-clinical-pathways-for-cancer-care-management 2026-08-24 monthly 0.7 https://rjrindex.com/articles/appropriate-treatment-for-stage-1-and-2-her-2-positive-and-triple-negative-breast-cancer-by-immigrat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differential-and-cumulative-impact-of-metabolic-syndrome-traits-on-cardiovascular-renal-and-mortal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intravesical-sacituzumab-tirumotecan-in-participants-with-intermediate-risk-non-muscle-invasive-blad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evolving-mortality-trends-in-waldenstrom-marcroglobulinemia-a-21-year-analysis-1999-2020-using-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identifying-key-molecular-drivers-of-survival-and-therapeutic-targets-in-glioblastoma-through-integr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radiotherapy-integration-strategy-for-small-cell-lung-cancer-in-extensive-stage-rise-with-up-to-10 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-patient-advocacy-focused-rehabilitation-pilot-program-real-life-experience-in-enhancing-quality-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-pilot-exercise-program-in-breast-cancer-survivors-group-vs-individual-training-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-treatment-with-traditional-chinese-medicine-renshen-yangrong-tang-granules-for-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-receipt-of-palliative-interventions-across-disaggregated-hispanic-subgroups-with-late 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-atezolizumab-and-bevacizumab-with-or-without-transarterial-chemoembolization 2026-08-24 monthly 0.7 https://rjrindex.com/articles/towards-personalized-management-of-intraductal-papillary-mucinous-neoplasms-with-multimodal-artifici 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-outcomes-for-patients-diagnosed-with-small-cell-lung-cancer-between-a-university-and-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-race-gender-and-socioeconomic-status-on-ewing-sarcoma-survival-over-two-decades 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combining-novel-mirna-biomarkers-with-ca19-9-to-enhance-early-detection-of-pancreatic-ductal-adenoca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-trends-in-disability-adjusted-life-years-dalys-and-mortality-rates-of-pancreatic-cancer-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-iia-clinical-trial-of-abp1011t-monotherapy-in-patients-with-advanced-malignant-solid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/venous-thrombosis-prophylaxis-in-oncology-knowledge-practice-and-attitude-study-among-oncologists 2026-08-24 monthly 0.7 https://rjrindex.com/articles/medical-students-interest-and-exposure-to-oncology-in-nigeria-implications-for-workforce-developme 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-trends-in-prevalence-of-pancreatic-cancer-in-adults-aged-70-and-older-a-global-burden-of-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/renal-cell-carcinoma-survival-in-the-immunotherapy-era-a-comprehensive-analysis-of-healthcare-and-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-identification-of-facilitators-and-barriers-in-the-pre-emergency-care-pathway-by-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diverging-paths-identifying-barriers-to-and-increasing-accessibility-of-a-survivorship-program-in-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gut-dysbiosis-as-a-potential-guide-for-immunotherapy-discontinuation-after-2-years-in-non-small-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-trial-of-a-supportive-oncology-care-at-home-intervention-for-patients-with-cancer-receivi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/age-acceleration-among-adolescent-and-young-adult-patients-with-ewing-sarcoma-and-osteosarcoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-the-presence-of-malignant-ascites-and-survival-outcomes-of-gastric-cancer-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimizing-an-ngs-low-pass-based-method-to-detect-genomic-instability-as-a-parp-inhibitor-predictive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/monitoring-populations-of-tumor-macrophage-fusion-cells-in-blood-prognosticates-pfs-and-os-in-pan-me 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-immunotherapy-of-hepatocellular-carcinoma-a-single-institution-experience-at-mount-sina 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-iii-study-of-the-safety-and-efficacy-of-intraperitoneal-imnn-001-in-combination-with-neoadj 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-retrospective-observational-analysis-examining-liquid-biopsies-with-tissue-biopsies-in-patients-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-by-dna-mismatch-repair-mmr-status-in-patients-pts-with-high-risk-endometrial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-use-of-educational-videos-in-a-medical-oncology-sarcoma-clinic-to-improve-patient-kno 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beyond-survival-prospective-longitudinal-insights-into-quality-of-life-after-hepatectomy-for-colore 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-of-mortality-in-lung-cancer-patients-in-the-era-of-immunotherapy-and-targeted-therapy-a-si 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trial-in-progress-tagged-a-phase-2-study-using-low-dosemetronomic-trabectedin-gemcitabine-and-da 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-gut-microbiota-gm-and-antibiotic-atb-use-on-immunotherapy-efficacy-in-patients-with-lu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-first-in-class-kif11-degrader-antibody-conjugate-dac-as-a-potential-therapy-targeting-a-broad-sp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-large-language-model-llm-based-multi-agent-framework-for-risk-stratification-and-treatment-recom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diagnostic-properties-of-a-novel-ctdna-assay-for-lung-cancer-detection 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-seer-stat-analysis-of-epidemiological-and-anatomical-prognostic-indicators-of-mesothelioma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-evaluation-of-neoadjuvant-chemoradiotherapy-plus-thymalfasin-and-tislelizumab-fo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-bat8006-a-folate-receptor-a-fra-antibody-drug-conjugate-in-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterizing-unmet-supportive-care-needs-in-diverse-adolescent-and-young-adult-cancer-survivors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-perioperative-complications-on-ctdna-based-mrd-detection-and-prognosis-insights-from-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ultrasensitive-ctdna-profiling-to-identify-long-term-survivors-in-phase-i-immunotherapy-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparing-real-world-treatment-patterns-and-outcomes-of-zanubrutinib-and-acalabrutinib-in-cllsll-at 2026-08-24 monthly 0.7 https://rjrindex.com/articles/liquid-biopsy-informed-precision-oncology-clinical-trial-to-evaluate-the-utility-of-ctdna-genomic-pr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-toxicity-of-pembrolizumab-in-addition-to-neoadjuvant-platinum-based-chemotherapy-napc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-prospective-study-to-evaluate-the-efficacy-of-resection-for-initially-unresectable-hep 2026-08-24 monthly 0.7 https://rjrindex.com/articles/endometrial-cancer-mortality-in-the-us-insights-into-inequities-across-demographics-and-regions 2026-08-24 monthly 0.7 https://rjrindex.com/articles/swog-s2302-pragmatica-lung-a-pragmatic-trial-designed-to-increase-participant-representation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-study-of-dk2-sup10sup-egfr-a-tumor-targeted-il2-x-il10-dual 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-in-clinical-outcomes-of-early-stage-triple-negative-breast-cancer-treated-with-ne 2026-08-24 monthly 0.7 https://rjrindex.com/articles/co-expressing-pattern-of-multiple-biomakers-and-dynamic-change-of-claudin182-expression-after-syste 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ib-and-ii-study-of-ribociclib-with-trastuzumab-plus-endocrine-therapy-in-hrher2-advanced-br 2026-08-24 monthly 0.7 https://rjrindex.com/articles/laparoscopic-versus-open-liver-resection-for-colorectal-liver-metastasis-an-individual-participant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/antibody-drug-conjugates-treatment-response-score-adc-trs-for-sequencing-trastuzuamb-deruxtecan-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dato-base-a-phase-ii-study-of-datopotamab-deruxtecan-for-patients-with-breast-cancer-brain-metastas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gold-complex-2g-and-its-role-in-immunogenic-cell-death-and-antitumor-immunity-in-malignant-pleural-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/napistar-1-01-an-international-phase-iii-trial-of-the-novel-adc-tub-040-in-platinum-resistant-ovar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-i-multicenter-open-label-study-of-ub-vv111-in-combination-with-rapamycin-in-relapsedrefra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-cemiplimab-with-platinum-doublet-chemotherapy-and-cetuximab-in-locoregionally-advanced-h 2026-08-24 monthly 0.7 https://rjrindex.com/articles/allo-316-in-advanced-clear-cell-renal-cell-carcinoma-ccrcc-updated-results-from-the-phase-1-trave 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-related-endocrinopathy-in-cancer-patients-receiving-immune-checkpoint-inhibitor-therapy-in-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ibrafi-v600e-papillary-thyroid-cancer-updated-analysis-of-real-world-patient-data 2026-08-24 monthly 0.7 https://rjrindex.com/articles/starlite-2-phase-2-study-of-nivolumab-plus-sup177sup-lutetium-labeled 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-qls31905-in-patients-with-advanced-solid-tumors-updated-data-from-phase-1-st 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transcriptomic-biomarkers-of-therapeutic-response-to-antibody-drug-conjugates-in-metastatic-breast-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/zl-1310-a-dll3-adc-in-patients-with-extensive-stage-small-cell-lung-cancer-ph1-trial-update 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterizing-transportation-need-and-missed-visits-among-patients-receiving-radiotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-tumor-informed-ctdna-based-molecular-residual-disease-mrd-with-clinical-outcomes-fo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/vaccination-by-homologous-antigenic-loading-with-doc1021-as-adjuvant-therapy-for-glioblastoma-phase 2026-08-24 monthly 0.7 https://rjrindex.com/articles/alectinib-as-neoadjuvant-treatment-in-potentially-resectable-stage-iii-alk-positive-nsclc-final-ana 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-cardiovascular-outcomes-of-carfilzomib-in-relapsed-or-refractory-multiple-myeloma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dietary-risk-factors-associated-with-colorectal-polyp-risk-and-potential-for-progression-to-malignan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-cemiplimab-in-cutaneous-basal-cell-carcinoma-of-the-head-and-neck 2026-08-24 monthly 0.7 https://rjrindex.com/articles/monitoring-botensilimab-and-balstilimab-induced-t-cell-dynamics-in-refractory-mismatch-repair-profi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-assessment-of-carboplatin-with-etoposide-and-high-dose-ifosfamide-in-reecur-an-internation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identifying-key-predictors-of-msimmr-status-in-colorectal-cancer-insights-from-a-real-world-clinic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-insights-in-skin-melanoma-a-study-of-differential-diagnostic-tissue-markers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-and-safety-of-adjuvant-therapy-in-patients-with-high-risk-melanoma-harboring-braf 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-mortality-due-to-laryngeal-carcinoma-a-systemic-analysis-of-the-global-burden-of-disease 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-exploratory-study-of-neoadjuvant-tislelizumab-combined-with-tp-regimen-for-the-comprehensive-trea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-8-year-single-institution-review-of-demographic-trends-and-treatment-patterns-among-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-impact-of-metronomic-therapy-methotrexate-and-celecoxib-and-cisplatin-based-radiochemo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-prognostic-role-of-tp53-mutations-in-mutyh-associated-colorectal-cancers-mutyh-crcs 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-two-decade-review-of-thyroid-cancer-mortality-among-older-adults-in-the-us 2026-08-24 monthly 0.7 https://rjrindex.com/articles/standard-dose-vs-fixed-dose-capecitabine-in-patients-with-advanced-gastrointestinal-and-metastatic-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identifying-unmet-cancer-survivor-needs-in-a-background-of-comprehensive-and-free-health-care-a-cro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-atezolizumab-immune-related-adverse-events-based-on-the-us-faers-database 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-effectiveness-and-acceptability-of-single-session-acupuncture-with-infusion-therapy-at-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-tislelizumab-in-combination-with-other-chemotherapy-agents-in-patients-with-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-immune-related-of-pembrolizumab-adverse-events-based-on-the-us-faers-database 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-relative-dose-intensity-rdi-of-perioperative-flot-in-resectable-and-locally-advanced-gas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diffusing-capacity-for-carbon-monoxide-dlco-change-and-outcome-in-advanced-non-small-cell-lung-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-records-to-timelines-a-llm-based-approach-for-summarizing-oncology-patient-history 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cerebrospinal-fluid-proteome-during-chemotherapy-for-childhood-leukemia-identifying-pathways-associ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-risk-factors-of-immune-mediated-liver-injury-caused-by-immune-checkpoint-inhibitors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hypothyroidism-related-to-immunotherapy-in-elderly-adults-analysis-of-a-colombian-oncology-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/waveline-010-zilovertamab-vedotin-plus-r-chp-versus-r-chop-in-untreated-diffuse-large-b-cell-lympho 2026-08-24 monthly 0.7 https://rjrindex.com/articles/obesity-as-a-predictor-of-in-hospital-outcomes-in-solid-tumours-with-cardiovascular-comorbidities 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ethnic-disparities-in-unmet-supportive-care-needs-and-outcomes-among-older-ambulatory-cancer-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-preferences-of-patients-caregivers-and-physicians-in-follicular-lymphoma-fl-a-global 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-hla-class-i-expression-on-the-tumor-immune-microenvironment-and-prognosis-in-prostate-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/time-from-diagnosis-to-surgery-for-stage-i-non-small-cell-lung-cancer-among-native-hawaiians-and-oth 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gender-place-of-death-and-racial-disparities-in-the-reporting-odds-ratio-of-cardiovascular-disease 2026-08-24 monthly 0.7 https://rjrindex.com/articles/additive-clinical-utility-of-tissue-biomarkers-of-microsatellite-instability-msi-status-and-tumor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/designing-a-novel-proactive-cv-clinic-model-to-address-cardiovascular-risk-in-prostate-cancer-surviv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-cardiovascular-mortality-among-patients-with-hematological-malignancies-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-factors-associated-with-surgical-resection-rate-and-survival-prognosis-after-conversion-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-epic-slicerdicer-to-assess-pregnancy-rates-in-adolescent-and-young-adult-patients-with-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-factors-in-adolescents-and-young-adults-associated-with-hepatobiliary-cancer-a-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/relationship-between-access-to-shelter-arrangement-and-adherence-to-breast-cervical-and-colorectal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrative-analysis-of-vb1016-and-atezolizumab-in-advanced-hpv16-positive-cervical-cancer-linking 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mortality-trends-due-to-endometrial-cancer-in-the-united-states-a-retrospective-analysis-from-1999 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-effect-of-hifu-treatment-on-liver-metastasis-of-colorectal-cancer-in-mice-and-its-impact-on-immu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-dose-expansion-study-of-zg006-a-trispecific-t-cell-engager-targeting-cd3dll3dll3-as-mo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-molecular-and-immunohistochemical-profiling-of-endometrial-carcinomas-insights-into-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-effectiveness-of-circulating-tumor-dna-in-recurrent-early-stage-non-small-cell-lung-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/regional-and-demographic-trends-in-mortality-from-breast-cancer-and-respiratory-diseases-in-united-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-early-onset-gastrointestinal-cancers-a-comprehensive-analysis-of-us-cancer-statistics-20 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unveiling-the-hidden-burden-prevalence-and-disparities-of-cancer-diagnosed-in-emergency-and-hospita 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-conflicts-of-interest-in-clinical-trials-published-in-jco-a-large-language-model-assist 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-survivorship-related-communication-gaps-to-develop-a-community-health-worker-led-interven 2026-08-24 monthly 0.7 https://rjrindex.com/articles/recombinant-human-adenovirus-type-5-h101-combined-with-anti-pd-1-monoclonal-antibody-in-the-treatm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-rw-outcomes-of-patients-pts-with-lower-risk-myelodysplastic-syndrome-lr-mds-receivi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/celecoxib-vs-placebo-in-combination-with-chemotherapy-for-non-small-cell-lung-cancer-a-systematic-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/potential-risk-factors-course-of-disease-and-clinical-outcomes-of-neuroendocrine-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-mixed-methods-feasibility-study-to-evaluate-and-assess-the-clinical-utility-of-multidisciplinary-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reduced-length-of-stay-as-an-alternative-to-full-outpatient-car-t-services 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-prognostic-accuracy-in-lung-cancer-brain-metastases-through-histopathologic-feature-integr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/out-of-pocket-cost-modeling-of-europa-trial-arms-for-adjuvant-breast-cancer-therapy-five-days-of-ra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/athena-breast-a-real-world-pilot-of-an-artificial-intelligence-ai-chatbot-using-therapy-guideline 2026-08-24 monthly 0.7 https://rjrindex.com/articles/current-treatment-patterns-for-early-breast-cancer-among-healthcare-professionals-and-concordance-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quantitative-ihc-and-ai-based-evaluation-of-her2-low-and-ultra-low-expression-in-breast-cancer-speci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radiotherapy-utilization-at-the-fourth-most-populous-province-in-indonesia-a-single-centre-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-patterns-use-of-healthcare-resources-and-clinical-characteristics-of-patients-with-castr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/verification-of-the-breastest-assay-in-an-australian-population-a-novel-liquid-biopsy-assay-measuri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-use-of-an-electronic-medical-record-emr-best-practice-advisory-bpa-to-facilitate-oncofertili 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-of-locoregional-recurrence-among-patients-with-breast-cancer-treated-with-breast-conservi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/health-related-quality-of-life-in-metastatic-hormone-sensitive-prostate-cancer-mhspc-insights-fro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-dna-repair-genetic-alterations-identified-by-circulating-tumor-dna-on-sensitivity-to-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-the-efficacy-of-alk-inhibitors-in-alk-positive-non-small-cell-lung-cancer-a-real-world-da 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-demographics-and-outcomes-of-breast-cancer-in-females-undergoing-mastectomy-in-rural 2026-08-24 monthly 0.7 https://rjrindex.com/articles/acute-bowel-symptoms-following-relugolix-and-stereotactic-body-radiotherapy-for-localized-prostate-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breast-cancer-care-capacity-in-cote-divoire-insights-from-a-novel-multidisciplinary-provider-surve 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ccr8-positive-tregs-and-their-correlation-with-immunotherapy-response-in-advanced-non-small-cell-lun 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparing-in-hospital-outcomes-between-total-parenteral-nutrition-and-enteral-feeding-in-esophageal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/raceethnicity-reporting-and-representation-in-clinical-trials-presented-at-the-american-society-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-of-second-primary-hematological-malignancy-post-car-t-cell-therapy-in-relapsedrefractory-multi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-analysis-of-vte-incidence-in-lung-cancer-a-comprehensive-assessment-of-the-khorana-score 2026-08-24 monthly 0.7 https://rjrindex.com/articles/obesity-paradox-in-non-small-cell-lung-cancer-nsclc-patients-on-immune-checkpoint-inhibitors-real 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-burden-of-multiple-myeloma-analysis-from-1980-to-2021 2026-08-24 monthly 0.7 https://rjrindex.com/articles/antitumoral-immunity-in-colorectal-liver-metastases-histopathological-growth-patterns-and-tertiary 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pertuzumab-plus-trastuzumab-pt-in-patients-pts-with-bladder-bc-and-ovarian-cancer-oc-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-analysis-of-t-cell-subsets-and-vessel-features-in-matched-primary-colorectal-tumors-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-window-of-opportunity-study-for-preoperative-brigatinib-in-resectable-anaplastic-lymphoma-kinase 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-outcomes-of-cdk46-inhibitors-plus-endocrine-therapy-versus-chemotherapy-in-hrher2-breas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-immunotherapy-and-surgery-in-patients-with-stage-iiib-iiic-n3-non-small-cell-lung-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-a-highly-sensitive-ctdna-assay-to-map-the-evolution-of-metastatic-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/post-mastectomy-surveillance-a-patient-reported-survey-of-110-women-with-li-fraumeni-syndrome 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-long-course-versus-short-course-chemoradiotherapy-combined-with-immunotherapy-for-pmmrm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rurality-and-screening-colonoscopy-participation-in-patients-with-lynch-syndrome 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlation-between-the-efficacy-of-anti-her-2-targeted-therapy-and-ctdna-status-a-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/signatera-ctdna-in-stage-ii-crc-a-retrospective-comparison-with-traditional-risk-factors-for-surviv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/her2-positivehormone-positive-vs-her2-positivehormone-negative-breast-cancer-clinical-presentatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-radiological-characteristics-of-intermediate-and-high-risk-cases-in-the-brazilian-early 2026-08-24 monthly 0.7 https://rjrindex.com/articles/discrepancies-between-germline-and-somatic-laboratories-in-the-reporting-of-germline-cancer-predispo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/accurate-differentiation-of-malignant-and-benign-gastric-lesions-using-cell-free-dna-biomarkers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/next-generation-u-net-encoder-decoder-for-accurate-automated-ctc-detection-from-images-of-peripher 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-efficacy-and-safety-of-cadonilimab-pd-1ctla-4-bispecific-antibody-in-patients-with-adv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-pemetrexed-based-regimens-in-primary-central-nervous-system-lymphoma-a-single-center-ex 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-phase-ii-study-of-cabozantinib-cabo-with-nivolumab-nivo-and-ipilimumab-ipi-in-adva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/challenges-in-hiv-diffuse-large-b-cell-lymphoma-in-afro-caribbean-patients-in-a-nyc-hospital 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-and-outcomes-of-lung-abscess-in-hospitalized-lung-cancer-patients-insights-from-the-nati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fibroblast-growth-factor-receptor-3-ifgfr3i-alteration-status-and-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/driving-precision-oncology-in-lung-cancer-patient-stratification-through-comprehensive-genomic-prof 2026-08-24 monthly 0.7 https://rjrindex.com/articles/initial-results-of-a-screening-trial-for-evaluating-oncogenic-drivers-in-japanese-patients-with-surg 2026-08-24 monthly 0.7 https://rjrindex.com/articles/postoperative-radiotherapy-and-survival-outcomes-in-pn2-non-small-cell-lung-cancer-with-positive-sur 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-outcomes-of-minimally-invasive-surgery-and-open-surgery-for-rectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/anlotinib-in-combination-with-penpulimab-and-chemotherapy-as-first-line-treatment-for-extensive-stag 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-therapy-in-resectable-small-cell-lung-cancer-a-systematic-review-and-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-analysis-comparing-chemoradiation-with-durvalumab-vs-chemoradiation-alone-in-locally-adva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/boolean-network-modeling-the-first-step-toward-a-new-understanding-of-breast-cancer-heterogeneity 2026-08-24 monthly 0.7 https://rjrindex.com/articles/thrombotic-events-and-mortality-associated-with-bispecific-antibodies-in-lung-cancer-a-systematic-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trajectories-of-patient-reported-cognitive-function-and-age-related-conditions-in-a-longitudinal-obs 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-cardioprotective-therapies-in-preventing-cardiotoxicity-in-breast-cancer-patients-treate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unveiling-the-differences-in-tumor-immune-microenvironment-between-ikrasi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimizing-board-exam-outcomes-a-structured-exam-preparation-curriculum-for-hematologyoncology-fel-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-in-3-year-cancer-specific-and-overall-survival-for-metastatic-renal-cell-carcinom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lenvatinib-plus-pembrolizumab-and-chemotherapy-versus-chemotherapy-in-advanced-metastatic-gastroeso 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-in-major-adverse-cardiovascular-and-cerebrovascular-events-and-healthcare-resourc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-cardiovascular-disease-mortality-among-pancreatic-cancer-patients-in-the-us-1999-2023-u 2026-08-24 monthly 0.7 https://rjrindex.com/articles/modifiable-risk-factors-genetic-characteristics-and-survival-in-early-onset-cholangiocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/access-to-new-therapies-and-outcomes-in-brazilian-patients-with-metastatic-non-small-cell-lung-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-risk-of-pathogenic-germline-variants-among-164774-adult-cancers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-survival-and-role-of-chemotherapy-in-patients-with-adrenocortical-carcinoma-insights 2026-08-24 monthly 0.7 https://rjrindex.com/articles/second-primary-malignancy-in-patients-with-diffuse-large-b-cell-lymphoma-dlbcl-receiving-chimeric 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-toxicity-of-low-doses-versus-standard-dose-enzalutamide-in-advanced-prostate-cancer-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunological-correlates-from-phase-i-study-of-carv3-team-e-in-patients-with-recurrent-glioblastoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/initial-report-of-memory-avoidance-whole-brain-radiotherapy-to-treat-brain-metastases-a-prospective 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-age-in-the-clinical-risk-stratification-of-patients-with-idh-mutant-gliomas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/non-hodgkin-lymphomas-in-a-turkish-pediatric-cancer-center-a-developing-country-model 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-donafenib-combined-with-pd-l1-inhibitors-plus-tace-for-unresectable-hepatoce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/healthcare-resource-use-in-the-management-of-advanced-epithelial-ovarian-cancer-in-canada 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatial-and-bulk-transcriptomic-analysis-of-skin-kaposi-sarcoma-lesions-differences-by-disease-char 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-combination-therapy-versus-monotherapy-in-advanced-non-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mfolfirinox-efficacy-as-rescue-regimen-for-patients-with-metastatic-refractory-colorectal-cancer-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-a-novel-oral-medication-delivery-device-on-patient-engagement-and-discontinuation-in-indiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/insurance-coverage-of-germline-genetic-testing-for-ovarian-pancreatic-and-early-onset-colorectal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integration-of-next-generation-rna-sequencing-based-mammaprint-and-blueprint-analysis-in-clinical-de 2026-08-24 monthly 0.7 https://rjrindex.com/articles/visual-capturing-and-profiling-of-circulating-tumor-cells-from-breast-cancer-patients-blood-via-com 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-safety-and-efficacy-of-crispraacas12b-supmaxsup-modifi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mechanism-of-the-synergistic-enhancement-of-response-to-immunotherapy-in-advanced-cholangiocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/darolutamide-plus-androgen-deprivation-therapy-adt-in-patients-with-high-risk-biochemical-recurren 2026-08-24 monthly 0.7 https://rjrindex.com/articles/personalized-recurrence-risk-stratification-in-surgically-resected-non-small-cell-lung-cancer-multi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/maintenance-with-ose2101-plus-folfiri-vs-folfiri-alone-after-folfirinox-ffx-induction-in-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patients-digital-health-needs-and-the-potential-impact-of-a-digital-health-navigator-on-the-oncolog 2026-08-24 monthly 0.7 https://rjrindex.com/articles/new-onset-osteopeniaosteoporosis-among-long-term-survivors-of-breast-cancer-role-of-hormone-therap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlative-and-spatial-transcriptomic-analysis-of-olaparib-and-durvalumab-in-patients-with-recurren 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-ifebemtinib-in10018-combined-with-garsorasib-d-1553-in-kras-g12c-mutant-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/iberdomide-bortezomib-and-dexamethasone-ibervd-in-transplant-ineligible-tne-newly-diagnosed-mu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-utility-of-a-tumor-naive-circulating-tumor-dna-ctdna-test-to-predict-outcomes-in-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influence-of-pre-existing-autoimmune-disease-on-outcomes-in-patients-treated-with-cd-19-targeting-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-importance-of-time-to-treatment-in-early-onset-colon-cancer-a-national-cancer-database-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/public-awareness-adherence-and-cost-effectiveness-of-cancer-screening-programs-insights-from-nati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/digital-spatial-profiling-of-advanced-solid-tumors-and-lymphomas-from-a-phase-1-trial-of-copanlisib 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-summary-of-the-c406-cart-efficacy-and-safety-for-an-her-2-positive-breast-cancer-populatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/haic-plus-tae-combined-with-tislelizumab-and-surufatinib-in-unresectable-intrahepatic-cholangiocarci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sup212sup-pbvmt-a-net-therapy-in-somatostatin-receptor-2-sstr2-exp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-and-outcomes-of-triple-class-exposed-tce-patients-with-relapsedrefr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/results-of-a-phase-i-study-of-alpelisib-and-sacituzumab-govitecan-sg-in-patients-with-her2-negativ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/knowledge-and-barriers-to-breast-and-cervical-cancer-screening-in-rural-nigerian-communities-an-eth 2026-08-24 monthly 0.7 https://rjrindex.com/articles/results-from-phase-1-study-of-mycophenolate-mofetil-with-chemoradiation-in-newly-diagnosed-glioblast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/camrelizumab-plus-nab-paclitaxel-and-cisplatin-as-first-line-treatment-for-metastatic-triple-negativ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/primary-results-of-a-phase-2-study-of-cisplatin-sensitized-radiation-therapy-and-pembrolizumab-for-u 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-periodontal-microbiome-on-response-to-immunotherapy-in-patients-with-advanced-non-small-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploratory-analysis-of-responders-from-the-phase-3-ev-302-trial-of-enfortumab-vedotin-plus-pembroli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/growth-recovery-in-patients-with-ibrafi-altered-pediatric-low-grade-gli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-results-of-a-phase-2-study-of-hdaci-chidamide-and-pd-1-inhibitor-for-advanced-urothelial-carci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-adjuvant-pembrolizumab-in-clinical-stage-iibc-melanoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enterprise-level-ai-screening-for-oncology-trials-improving-patient-identification-with-oncollm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-tqb2102-a-novel-bispecific-anti-her2-antibody-drug-conjugate-in-patients-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/durvalumab-plus-carboplatinpaclitaxel-followed-by-durvalumab-with-or-without-olaparib-as-first-line 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-neoadj-osimertinib-osi-chemotherapy-ct-vs-ct-alone-in-resectable-r-epidermal-g 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-anlotinib-plus-penpulimab-as-first-line-treatment-for-persistent-recurrent-or 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-use-of-docetaxel-as-a-radiosensitizer-in-patients-with-head-and-neck-cancer-unsuitable-for-cispl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/onitt-a-phase-i-study-of-nanoliposomal-irinotecan-with-talazoparib-or-temozolomide-in-children-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-of-salivary-cd44-and-total-protein-levels-in-patients-with-oral-cavity-dysplasia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-second-primary-cancer-incidence-by-primary-colorectal-cancer-location 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunotherapy-vs-chemotherapy-run-in-followed-by-pembrolizumab-plus-nab-paclitaxel-in-metastatic-tr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/examining-age-specific-trends-in-the-incidence-of-human-papillomavirus-associated-oropharyngeal-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-medicare-advantage-ma-on-timely-initiation-of-pembrolizumab-among-dmmrmsi-h-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/race-specific-survival-prediction-models-for-de-novo-metastatic-breast-cancer-using-machine-learning 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparing-ibrca12i-copy-number-loss-assessment-in-circulating-tumor-dn 2026-08-24 monthly 0.7 https://rjrindex.com/articles/personalized-medicine-in-colorectal-mucinous-adenocarcinoma-mac-machine-learning-based-prognostic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-precision-oncology-for-haitian-breast-cancer-patients-through-deep-learning-enabled-comput 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementation-of-a-pre-treatment-readiness-tool-for-soft-tissue-and-bone-sarcoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/deep-learning-as-a-predictor-for-mammaprint-risk-group-from-pathology-slides-in-chinese-early-stage 2026-08-24 monthly 0.7 https://rjrindex.com/articles/melanoma-dormancy-predictors-of-relapse-in-resected-early-stage-cutaneous-melanoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/guard-01-a-prospective-study-of-efbemalenograstim-alfa-as-primary-prophylaxis-for-concurrent-chemo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-of-non-breast-cancer-related-mortality-in-breast-cancer-and-dependence-on-disease-characteristi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dinutuximab-beta-for-the-treatment-of-ewing-sarcoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cdk-inhibitors-and-radiation-therapy-in-breast-cancer-hematologic-toxicity-and-survival-implication 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-novel-muc1-c-targeted-near-infrared-imaging-agent-for-fluorescence-guided-surgery-of-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interplatform-and-cross-cohort-meta-analysis-of-tumor-transcriptomics-to-predict-non-small-cell-lung 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-safety-profiles-of-lutetium-177-and-enzalutamide-a-pharmacovigilance-study-and-dispropo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-alphafold-2-to-predict-stabilizing-mutations-for-the-r337h-variant-in-the-tetramerization-dom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-survival-mortality-determinants-and-demographic-factors-in-pancreatic-carcinoma-an-anal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-and-regional-burden-of-high-bmi-related-pancreatic-cancer-from-1990-to-2021-an-analysis-of-g 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prospective-single-arm-phase-ii-study-of-surufatinib-in-combination-with-gemcitabine-and-nab-pac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-efficacy-and-safety-of-donafenib-as-postoperative-adjuvant-therapy-in-patients-at-high-risk-of-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differences-in-patient-pt-characteristics-and-therapy-choice-across-treatment-tx-groups-in-local 2026-08-24 monthly 0.7 https://rjrindex.com/articles/distinct-microenvironment-phenotypes-across-tumor-vascular-and-immune-compartments-from-ramuciruma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preferred-first-line-1l-treatment-for-metastatic-urothelial-carcinoma-muc-after-prior-immune-che 2026-08-24 monthly 0.7 https://rjrindex.com/articles/precision-oncology-in-pediatric-brain-tumors-real-world-experience-from-a-middle-income-country 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-prediction-and-prognostic-analysis-on-immunotherapy-and-tkis-combination-treated-mrcc-by-cu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-nephrectomy-on-the-clinical-outcomes-of-first-line-immunotherapy-and-tyrosine-kinase-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-application-of-a-novel-split-type-robotic-system-carina-platform-for-esophageal-surgery 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prospective-single-arm-phase-ii-study-to-evaluate-the-efficacy-and-safety-of-perioperative-tisle 2026-08-24 monthly 0.7 https://rjrindex.com/articles/womens-breast-cancer-mortality-trends-the-impact-of-lifestyle-factors-from-the-2021-global-burden 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clobazam-as-an-add-on-treatment-for-medically-refractory-brain-tumor-related-epilepsy 2026-08-24 monthly 0.7